{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:05:11Z","timestamp":1792188311547,"version":"4.4.0"},"reference-count":628,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1002\/hep.31065","type":"journal-article","created":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T03:45:17Z","timestamp":1576899917000},"page":"671-722","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":913,"title":["Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases"],"prefix":"10.1097","volume":"72","author":[{"given":"Cara L.","family":"Mack","sequence":"first","affiliation":[{"name":"Department of Pediatrics,University of Colorado School of Medicine,Aurora,CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6776-0336","authenticated-orcid":false,"given":"David","family":"Adams","sequence":"additional","affiliation":[{"name":"Centre for Liver Research,University of Birmingham,Birmingham,UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Assis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,Yale School of Medicine,New Haven,CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanda","family":"Kerkar","sequence":"additional","affiliation":[{"name":"Golisano Children's Hospital at Strong,University of Rochester Medical Center,New York,NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Endocrinology,Hannover Medical School,Hannover,Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlyn J.","family":"Mayo","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Diseases,University of Texas SW Medical Center,Dallas,TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Vierling","sequence":"additional","affiliation":[{"name":"Medicine and Surgery,Baylor College of Medicine,Houston,TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouaz","family":"Alsawas","sequence":"additional","affiliation":[{"name":"Mayo Clinic Minnesota,Rochester,MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Murad","sequence":"additional","affiliation":[{"name":"Mayo Knowledge and Encounter Research Unit,Mayo Clinic College of Medicine,Rochester,MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Czaja","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Mayo Clinic College of Medicine,Rochester,MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"key":"hep31065-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/hep.28345","article-title":"AASLD practice guidelines: the past, the present, and the future","volume":"63","year":"2016","journal-title":"Hepatology"},{"key":"hep31065-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"hep31065-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","year":"2008","journal-title":"BMJ"},{"key":"hep31065-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/jebm.12018","article-title":"Understanding GRADE: an introduction","volume":"6","year":"2013","journal-title":"J Evid Based Med"},{"key":"hep31065-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","article-title":"Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico\u2010laboratory and histological characteristics","volume":"21","year":"2015","journal-title":"World J Gastroenterol"},{"key":"hep31065-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/liv.14081","article-title":"Racial disparities in presentation and outcomes of paediatric autoimmune hepatitis","volume":"39","year":"2019","journal-title":"Liver Int"},{"key":"hep31065-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0168-8278(05)80279-X","article-title":"Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States","volume":"18","year":"1993","journal-title":"J Hepatol"},{"key":"hep31065-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"hep31065-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study","volume":"43","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"hep31065-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Population\u2010based epidemiology study of autoimmune hepatitis: a disease of older women?","volume":"25","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"hep31065-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry\u2010based cohort study","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"hep31065-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3109\/00365521.2014.946083","article-title":"Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands","volume":"49","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"hep31065-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20\u2010year experience","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"hep31065-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.dld.2010.01.002","article-title":"Autoimmune hepatitis in children\u2013impact of cirrhosis at presentation on natural history and long\u2010term outcome","volume":"42","year":"2010","journal-title":"Dig Liver Dis"},{"key":"hep31065-bib-0015-20241017","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.26454","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history","volume":"58","year":"2013","journal-title":"Hepatology"},{"key":"hep31065-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"e1237","DOI":"10.1542\/peds.2015-0578","article-title":"Incidence and characteristics of autoimmune hepatitis","volume":"136","year":"2015","journal-title":"Pediatrics"},{"key":"hep31065-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s10620-017-4675-y","article-title":"Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis","volume":"62","year":"2017","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0018-20241017","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.42.5.599","article-title":"The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis","volume":"42","year":"1998","journal-title":"Gut"},{"key":"hep31065-bib-0019-20241017","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1155\/2001\/279637","article-title":"Autoimmune hepatitis: clinical manifestations and diagnostic criteria","volume":"15","year":"2001","journal-title":"Can J Gastroenterol"},{"key":"hep31065-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/1751-2980.12085","article-title":"Autoimmune hepatitis in southern Israel: a 15\u2010year multicenter study","volume":"14","year":"2013","journal-title":"J Dig Dis"},{"key":"hep31065-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0210-5705(03)70452-X","article-title":"Incidence and prevalence of autoimmune hepatitis in the area of the Hospital de Sagunto (Spain)","volume":"27","year":"2004","journal-title":"Gastroenterol Hepatol"},{"key":"hep31065-bib-0022-20241017","first-page":"402","article-title":"Incidence of adult form of autoimmune hepatitis in Valencia (Spain)","volume":"72","year":"2009","journal-title":"Acta Gastroenterol Belg"},{"key":"hep31065-bib-0023-20241017","first-page":"1022","article-title":"Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis","volume":"52","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"hep31065-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska natives","volume":"97","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1046\/j.1440-1746.2001.02646.x","article-title":"Autoimmune hepatitis in Singapore: a rare syndrome affecting middle\u2010aged women","volume":"16","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"hep31065-bib-0026-20241017","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1155\/2007\/757906","article-title":"Retrospective review of pediatric and adult autoimmune hepatitis in two quaternary care centres in British Columbia: increased prevalence seen in British Columbia's First Nations community","volume":"21","year":"2007","journal-title":"Can J Gastroenterol"},{"key":"hep31065-bib-0027-20241017","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-065X.1999.tb01398.x","article-title":"The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases","volume":"167","year":"1999","journal-title":"Immunol Rev"},{"key":"hep31065-bib-0028-20241017","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0198-8859(94)90008-6","article-title":"Chronic active autoimmune hepatitis in children. Strong association with a particular HLA\u2010DR6 (DRB1*1301) haplotype","volume":"41","year":"1994","journal-title":"Hum Immunol"},{"key":"hep31065-bib-0029-20241017","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","article-title":"Allelic basis for HLA\u2010encoded susceptibility to type 1 autoimmune hepatitis","volume":"112","year":"1997","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0030-20241017","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0198-8859(00)00234-2","article-title":"Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus","volume":"62","year":"2001","journal-title":"Hum Immunol"},{"key":"hep31065-bib-0031-20241017","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jhep.2006.07.034","article-title":"HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis","volume":"45","year":"2006","journal-title":"J Hepatol"},{"key":"hep31065-bib-0032-20241017","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/gene.2014.82","article-title":"HLA\u2010DRB1*03:01 and HLA\u2010DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type\u20101","volume":"16","year":"2015","journal-title":"Genes Immun"},{"key":"hep31065-bib-0033-20241017","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.510310110","article-title":"Cytotoxic T lymphocyte antigen\u20104 (CTLA\u20104) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis","volume":"31","year":"2000","journal-title":"Hepatology"},{"key":"hep31065-bib-0034-20241017","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510300412","article-title":"Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis","volume":"30","year":"1999","journal-title":"Hepatology"},{"key":"hep31065-bib-0035-20241017","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.dld.2014.02.003","article-title":"The association between cytotoxic T lymphocyte associated antigen\u20104, Fas, tumour necrosis factor\u2010alpha gene polymorphisms and autoimmune hepatitis: a meta\u2010analysis","volume":"46","year":"2014","journal-title":"Dig Liver Dis"},{"key":"hep31065-bib-0036-20241017","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1572-0241.2005.41053.x","article-title":"Fas polymorphisms influence susceptibility to autoimmune hepatitis","volume":"100","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0037-20241017","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1399-0039.2006.00794.x","article-title":"A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis","volume":"69","year":"2007","journal-title":"Tissue Antigens"},{"key":"hep31065-bib-0038-20241017","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jhep.2002.30084","article-title":"Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis","volume":"35","year":"2002","journal-title":"Hepatology"},{"key":"hep31065-bib-0039-20241017","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1746.2005.03532.x","article-title":"Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese","volume":"20","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"hep31065-bib-0040-20241017","article-title":"Association of STAT4 polymorphisms with susceptibility to type\u20101 autoimmune hepatitis in the Japanese population","volume":"8","year":"2013","journal-title":"PLoS ONE"},{"key":"hep31065-bib-0041-20241017","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.clim.2009.11.004","article-title":"The most severe forms of type I autoimmune hepatitis are associated with genetically determined levels of TGF\u2010beta1","volume":"134","year":"2010","journal-title":"Clin Immunol"},{"issue":"Suppl. 1","key":"hep31065-bib-0042-20241017","first-page":"S72","article-title":"MIF, MIF alleles, and prospects for therapeutic intervention in autoimmunity","volume":"33","year":"2013","journal-title":"J Clin Immunol"},{"key":"hep31065-bib-0043-20241017","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome\u2010wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","year":"2014","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0044-20241017","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.clinre.2014.10.009","article-title":"Interleukin\u201023 receptor genetic polymorphisms and ulcerative colitis susceptibility: a meta\u2010analysis","volume":"39","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"hep31065-bib-0045-20241017","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng1297-393","article-title":"Positional cloning of the APECED gene","volume":"17","year":"1997","journal-title":"Nat Genet"},{"key":"hep31065-bib-0046-20241017","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/08830185.2014.921162","article-title":"Pathogen infection as a possible cause for autoimmune hepatitis","volume":"33","year":"2014","journal-title":"Int Rev Immunol"},{"key":"hep31065-bib-0047-20241017","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12016-015-8493-8","article-title":"Environmental basis of autoimmunity","volume":"50","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"hep31065-bib-0048-20241017","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12072-010-9183-5","article-title":"Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management","volume":"4","year":"2010","journal-title":"Hepatol Int"},{"key":"hep31065-bib-0049-20241017","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2013.06.013","article-title":"Mucosal immunity in liver autoimmunity: a comprehensive review","volume":"46","year":"2013","journal-title":"J Autoimmun"},{"key":"hep31065-bib-0050-20241017","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2018.10.020","article-title":"Etiopathogenesis of autoimmune hepatitis","volume":"95","year":"2018","journal-title":"J Autoimmun"},{"key":"hep31065-bib-0051-20241017","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.semarthrit.2018.10.007","article-title":"Regulatory B cells: new players in inflammatory and autoimmune rheumatic diseases","volume":"48","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"hep31065-bib-0052-20241017","article-title":"Regulatory T cells: from discovery to autoimmunity","volume":"8","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"hep31065-bib-0053-20241017","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41586-019-1467-x","article-title":"Opposing T cell responses in experimental autoimmune encephalomyelitis","volume":"572","year":"2019","journal-title":"Nature"},{"key":"hep31065-bib-0054-20241017","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3389\/fimmu.2018.01333","article-title":"Mucosal\u2010associated invariant T cells in autoimmune diseases","volume":"9","year":"2018","journal-title":"Front Immunol"},{"key":"hep31065-bib-0055-20241017","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2009.07.011","article-title":"The role of chemokines in the recruitment of lymphocytes to the liver","volume":"34","year":"2010","journal-title":"J Autoimmun"},{"key":"hep31065-bib-0056-20241017","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","year":"1999","journal-title":"J Hepatol"},{"key":"hep31065-bib-0057-20241017","first-page":"1206","article-title":"The validity and importance of subtypes in autoimmune hepatitis: a point of view","volume":"90","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0058-20241017","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jhep.2009.01.020","article-title":"Autoimmune hepatitis in Italy: the Bologna experience","volume":"50","year":"2009","journal-title":"J Hepatol"},{"key":"hep31065-bib-0059-20241017","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/apt.13210","article-title":"Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype","volume":"41","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0060-20241017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5009\/gnl15352","article-title":"Diagnosis and management of autoimmune hepatitis: current status and future directions","volume":"10","year":"2016","journal-title":"Gut Liv"},{"key":"hep31065-bib-0061-20241017","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-010-1501-1","article-title":"Performance parameters of the conventional serological markers for autoimmune hepatitis","volume":"56","year":"2011","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0062-20241017","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16\u2010year prospective study","volume":"33","year":"2001","journal-title":"Hepatology"},{"key":"hep31065-bib-0063-20241017","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","article-title":"Behavior and significance of autoantibodies in type 1 autoimmune hepatitis","volume":"30","year":"1999","journal-title":"J Hepatol"},{"key":"hep31065-bib-0064-20241017","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/0891693021000056721","article-title":"Organ and non\u2010organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease","volume":"35","year":"2002","journal-title":"Autoimmunity"},{"key":"hep31065-bib-0065-20241017","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/0016-5085(93)90160-E","article-title":"Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis","volume":"105","year":"1993","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0066-20241017","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis","volume":"31","year":"1999","journal-title":"J Hepatol"},{"key":"hep31065-bib-0067-20241017","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0168-8278(00)80361-X","article-title":"Antibodies to soluble liver antigen: an additional marker in type 1 auto\u2010immune hepatitis","volume":"33","year":"2000","journal-title":"J Hepatol"},{"key":"hep31065-bib-0068-20241017","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.51.2.259","article-title":"Establishment of standardised SLA\/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics","volume":"51","year":"2002","journal-title":"Gut"},{"key":"hep31065-bib-0069-20241017","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1478-3231.2009.01986.x","article-title":"Significance of antibodies to soluble liver antigen\/liver pancreas: a large French study","volume":"29","year":"2009","journal-title":"Liver Int"},{"key":"hep31065-bib-0070-20241017","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1478-3231.2011.02502.x","article-title":"Prognostic implications of antibodies to Ro\/SSA and soluble liver antigen in type 1 autoimmune hepatitis","volume":"32","year":"2012","journal-title":"Liver Int"},{"key":"hep31065-bib-0071-20241017","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/liv.12022","article-title":"Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study","volume":"33","year":"2013","journal-title":"Liver Int"},{"key":"hep31065-bib-0072-20241017","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","year":"2002","journal-title":"Hepatology"},{"key":"hep31065-bib-0073-20241017","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1572-0241.2002.05479.x","article-title":"Antibodies to soluble liver antigen\/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis","volume":"97","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0074-20241017","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1007\/s10620-010-1268-4","article-title":"Autoantibodies as prognostic markers in autoimmune liver disease","volume":"55","year":"2010","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0075-20241017","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0016-5085(95)90215-5","article-title":"High\u2010titer antineutrophil cytoplasmic antibodies in type\u20101 autoimmune hepatitis","volume":"108","year":"1995","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0076-20241017","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0168-8278(96)80144-9","article-title":"Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass","volume":"24","year":"1996","journal-title":"J Hepatol"},{"key":"hep31065-bib-0077-20241017","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"p\u2010ANCAs in autoimmune liver disorders recognise human beta\u2010tubulin isotype 5 and cross\u2010react with microbial protein FtsZ","volume":"59","year":"2010","journal-title":"Gut"},{"key":"hep31065-bib-0078-20241017","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0002-9343(98)00325-8","article-title":"Clinical and immunological study of 7 patients with minocycline\u2010induced autoimmune phenomena","volume":"105","year":"1998","journal-title":"Am J Med"},{"key":"hep31065-bib-0079-20241017","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1007\/s10620-011-1769-9","article-title":"Cryptogenic chronic hepatitis and its changing guise in adults","volume":"56","year":"2011","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0080-20241017","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-1-2","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease","volume":"1","year":"2004","journal-title":"J Autoimmune Dis"},{"key":"hep31065-bib-0081-20241017","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/hep.510240515","article-title":"Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis","volume":"24","year":"1996","journal-title":"Hepatology"},{"key":"hep31065-bib-0082-20241017","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1196\/annals.1313.028","article-title":"Diagnostic value of anti\u2010F\u2010actin antibodies in a French multicenter study","volume":"1050","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"hep31065-bib-0083-20241017","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1111\/j.1572-0241.2006.00830.x","article-title":"Evaluation of F\u2010actin ELISA for the diagnosis of autoimmune hepatitis","volume":"101","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0084-20241017","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10875-006-9045-z","article-title":"Double reactivity against actin and alpha\u2010actinin defines a severe form of autoimmune hepatitis type 1","volume":"26","year":"2006","journal-title":"J Clin Immunol"},{"key":"hep31065-bib-0085-20241017","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2036.2011.04908.x","article-title":"Anti\u2010alpha actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1","volume":"35","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0086-20241017","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12016-007-8050-1","article-title":"Anti\u2010alpha\u2010actinin antibodies cross\u2010react with anti\u2010ssDNA antibodies in active autoimmune hepatitis","volume":"34","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"hep31065-bib-0087-20241017","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti\u2010LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","year":"1988","journal-title":"Hepatology"},{"key":"hep31065-bib-0088-20241017","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.1840160407","article-title":"Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis","volume":"16","year":"1992","journal-title":"Hepatology"},{"key":"hep31065-bib-0089-20241017","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1053\/jhep.2001.24101","article-title":"Characterization of autoantibodies against uridine\u2010diphosphate glucuronosyltransferase in patients with inflammatory liver diseases","volume":"33","year":"2001","journal-title":"Hepatology"},{"key":"hep31065-bib-0090-20241017","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0950-3528(96)90055-X","article-title":"Cytochromes P450 and UDP\u2010glucuronosyl\u2010transferases as hepatocellular autoantigens","volume":"10","year":"1996","journal-title":"Baillieres Clin Gastroenterol"},{"key":"hep31065-bib-0091-20241017","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0016-5085(96)70020-3","article-title":"Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis","volume":"111","year":"1996","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0092-20241017","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00351174","article-title":"Cytochrome P450 enzymes and UDP\u2010glucuronosyltransferases as hepatocellular autoantigens","volume":"23","year":"1996","journal-title":"Mol Biol Rep"},{"key":"hep31065-bib-0093-20241017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1568-9972(03)00051-X","article-title":"Autoantibodies directed against the UDP\u2010glucuronosyltransferases in human autoimmune hepatitis","volume":"3","year":"2004","journal-title":"Autoimmun Rev"},{"key":"hep31065-bib-0094-20241017","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/08916930410001702469","article-title":"Nonstandard antibodies as prognostic markers in autoimmune hepatitis","volume":"37","year":"2004","journal-title":"Autoimmunity"},{"key":"hep31065-bib-0095-20241017","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(93)91081-R","article-title":"Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis","volume":"105","year":"1993","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0096-20241017","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/gast.1997.v113.pm9247489","article-title":"A novel histological lesion in glucocorticoid\u2010responsive chronic hepatitis","volume":"113","year":"1997","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0097-20241017","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","article-title":"Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis","volume":"2","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0098-20241017","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00000478-200404000-00006","article-title":"Autoimmune hepatitis with centrilobular necrosis","volume":"28","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"hep31065-bib-0099-20241017","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1872-034X.2007.00125.x","article-title":"Clinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosis","volume":"37","year":"2007","journal-title":"Hepatol Res"},{"key":"hep31065-bib-0100-20241017","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"hep31065-bib-0101-20241017","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2141.1956.tb06700.x","article-title":"Biological interaction between lymphocytes and other cells","volume":"2","year":"1956","journal-title":"Br J Haematol"},{"key":"hep31065-bib-0102-20241017","first-page":"ZM01","article-title":"Emperipolesis\u2014a review","volume":"8","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"hep31065-bib-0103-20241017","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/modpathol.2016.267","article-title":"Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria","volume":"30","year":"2017","journal-title":"Mod Pathol"},{"key":"hep31065-bib-0104-20241017","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","year":"2005","journal-title":"Hepatology"},{"key":"hep31065-bib-0105-20241017","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis","volume":"110","year":"1996","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0106-20241017","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy","volume":"99","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0107-20241017","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4254\/wjh.v8.i28.1157","article-title":"Cirrhosis and autoimmune liver disease: current understanding","volume":"8","year":"2016","journal-title":"World J Hepatol"},{"key":"hep31065-bib-0108-20241017","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN Hepatology Committee position statement","volume":"66","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0109-20241017","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/BF01076196","article-title":"Severe chronic active liver disease. Prognostic significance of initial morphologic patterns","volume":"22","year":"1977","journal-title":"Am J Dig Dis"},{"key":"hep31065-bib-0110-20241017","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/0016-5085(84)90186-0","article-title":"Development and prognosis of histologic cirrhosis in corticosteroid\u2010treated hepatitis B surface antigen\u2010negative chronic active hepatitis","volume":"87","year":"1984","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0111-20241017","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/hep.1840080635","article-title":"Hepatocellular carcinoma in corticosteroid\u2010treated severe autoimmune chronic active hepatitis","volume":"8","year":"1988","journal-title":"Hepatology"},{"key":"hep31065-bib-0112-20241017","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1023\/A:1005638500236","article-title":"Hepatocellular carcinoma in autoimmune hepatitis","volume":"45","year":"2000","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0113-20241017","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1572-0241.2008.01922.x","article-title":"Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis","volume":"103","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0114-20241017","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","article-title":"Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow\u2010up and screening","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"hep31065-bib-0115-20241017","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1478-3231.2009.02092.x","article-title":"Identification and characterization of IgG4\u2010associated autoimmune hepatitis","volume":"30","year":"2010","journal-title":"Liver Int"},{"issue":"Suppl. 1","key":"hep31065-bib-0116-20241017","first-page":"48","article-title":"Clinical significance of immunoglobulin G4\u2013associated autoimmune hepatitis","volume":"46","year":"2011","journal-title":"J Gastroenterol"},{"key":"hep31065-bib-0117-20241017","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000355238","article-title":"Autoimmune hepatitis and immunoglobulin G4\u2013associated autoimmune hepatitis","volume":"31","year":"2013","journal-title":"Dig Dis"},{"key":"hep31065-bib-0118-20241017","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s10620-016-4213-3","article-title":"Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease","volume":"61","year":"2016","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0119-20241017","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jgh3.12046","article-title":"Non\u2010alcoholic fatty liver disease in patients with autoimmune hepatitis","volume":"2","year":"2018","journal-title":"JGH Open"},{"key":"hep31065-bib-0120-20241017","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: international autoimmune hepatitis group","volume":"18","year":"1993","journal-title":"Hepatology"},{"key":"hep31065-bib-0121-20241017","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"hep31065-bib-0122-20241017","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"hep31065-bib-0123-20241017","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jceh.2018.10.006","article-title":"Accuracy of the simplified criteria for autoimmune hepatitis in children: systematic review and decision analysis","volume":"9","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"hep31065-bib-0124-20241017","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1542-3565(04)00396-9","article-title":"Diagnosing autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group scoring system useful?","volume":"2","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0125-20241017","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00535-005-1711-z","article-title":"Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?","volume":"40","year":"2005","journal-title":"J Gastroenterol"},{"key":"hep31065-bib-0126-20241017","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","year":"2011","journal-title":"J Hepatol"},{"key":"hep31065-bib-0127-20241017","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","year":"2004","journal-title":"J Hepatol"},{"key":"hep31065-bib-0128-20241017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2008-1040641","article-title":"Natural history, clinical features, and treatment of autoimmune hepatitis","volume":"4","year":"1984","journal-title":"Semin Liver Dis"},{"key":"hep31065-bib-0129-20241017","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/MEG.0000000000000424","article-title":"Autoimmune liver disease and concomitant extrahepatic autoimmune disease","volume":"27","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep31065-bib-0130-20241017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients","volume":"35","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"hep31065-bib-0131-20241017","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1478-3231.2008.01904.x","article-title":"Features and consequences of untreated type 1 autoimmune hepatitis","volume":"29","year":"2009","journal-title":"Liver Int"},{"key":"hep31065-bib-0132-20241017","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cgh.2015.07.017","article-title":"Features and progression of asymptomatic autoimmune hepatitis in Italy","volume":"14","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0133-20241017","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0168-8278(94)80251-3","article-title":"The nature and prognostic implications of autoimmune hepatitis with an acute presentation","volume":"21","year":"1994","journal-title":"J Hepatol"},{"key":"hep31065-bib-0134-20241017","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/hch072","article-title":"Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the \u201cacute\u201d type","volume":"97","year":"2004","journal-title":"QJM"},{"key":"hep31065-bib-0135-20241017","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1440-1746.2008.05365.x","article-title":"Favorable outcomes of autoimmune hepatitis in a community clinic setting","volume":"23","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"hep31065-bib-0136-20241017","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","article-title":"Acute and acute severe (fulminant) autoimmune hepatitis","volume":"58","year":"2013","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0137-20241017","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.MPG.0000158524.30294.E2","article-title":"Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom","volume":"40","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0138-20241017","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00000478-199506000-00010","article-title":"Recent\u2010onset autoimmune hepatitis. Biopsy findings and clinical correlations","volume":"19","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"hep31065-bib-0139-20241017","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.30205","article-title":"Flare of autoimmune hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy","volume":"70","year":"2019","journal-title":"Hepatology"},{"key":"hep31065-bib-0140-20241017","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00535-010-0316-3","article-title":"Clinicopathological features of severe and fulminant forms of autoimmune hepatitis","volume":"46","year":"2011","journal-title":"J Gastroenterol"},{"key":"hep31065-bib-0141-20241017","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00535-008-2254-x","article-title":"Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute\u2010onset autoimmune hepatitis","volume":"43","year":"2008","journal-title":"J Gastroenterol"},{"key":"hep31065-bib-0142-20241017","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1872-034X.2011.00892.x","article-title":"Importance of computed tomography imaging features for the diagnosis of autoimmune acute liver failure","volume":"42","year":"2012","journal-title":"Hepatol Res"},{"key":"hep31065-bib-0143-20241017","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0028-1109146","article-title":"Presumed cryptogenic liver disease in Germany: high prevalence of autoantibody\u2010negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology","volume":"47","year":"2009","journal-title":"Z Gastroenterol"},{"key":"hep31065-bib-0144-20241017","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cgh.2008.08.043","article-title":"Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis","volume":"7","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0145-20241017","first-page":"217","article-title":"Current status of autoimmune hepatitis in Japan","volume":"62","year":"2008","journal-title":"Acta Med Okayama"},{"key":"hep31065-bib-0146-20241017","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/0016-5085(93)90656-W","article-title":"The nature and prognosis of severe cryptogenic chronic active hepatitis","volume":"104","year":"1993","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0147-20241017","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s10620-006-9665-4","article-title":"Corticosteroid\u2010responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis","volume":"52","year":"2007","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0148-20241017","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s10620-011-2017-z","article-title":"Autoantibody\u2010negative autoimmune hepatitis","volume":"57","year":"2012","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0149-20241017","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0b013e31802dbdfc","article-title":"Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background","volume":"42","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"hep31065-bib-0150-20241017","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MCG.0b013e3181c74e0d","article-title":"Concurrent autoimmune diseases in patients with autoimmune hepatitis","volume":"44","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"hep31065-bib-0151-20241017","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MEG.0b013e328350f95b","article-title":"Autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases","volume":"24","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep31065-bib-0152-20241017","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/liv.13236","article-title":"Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long\u2010term outcomes","volume":"37","year":"2017","journal-title":"Liver Int"},{"key":"hep31065-bib-0153-20241017","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis","volume":"7","year":"1987","journal-title":"Hepatology"},{"key":"hep31065-bib-0154-20241017","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0016-5085(98)70484-6","article-title":"Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1","volume":"114","year":"1998","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0155-20241017","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0029-1233535","article-title":"The autoimmune polyendocrinopathy\u2010candidiasis\u2010ectodermal dystrophy or autoimmune polyglandular syndrome type 1","volume":"29","year":"2009","journal-title":"Semin Liver Dis"},{"key":"hep31065-bib-0156-20241017","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"hep31065-bib-0157-20241017","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","year":"1993","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0158-20241017","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"hep31065-bib-0159-20241017","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.2196\/ijmr.9625","article-title":"Extrahepatic autoimmune diseases are prevalent in autoimmune hepatitis patients and their first\u2010degree relatives: survey study","volume":"7","year":"2018","journal-title":"Interact J Med Res"},{"key":"hep31065-bib-0160-20241017","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1023\/A:1026650118759","article-title":"Frequency and significance of anti\u2010gliadin and anti\u2010endomysial antibodies in autoimmune hepatitis","volume":"43","year":"1998","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0161-20241017","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/MEG.0000000000000172","article-title":"Seroprevalence of celiac disease in patients with autoimmune hepatitis","volume":"26","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep31065-bib-0162-20241017","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cgh.2007.12.002","article-title":"Autoimmune liver disease associated with celiac disease in childhood: a multicenter study","volume":"6","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0163-20241017","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(97)11222-3","article-title":"Coeliac disease hidden by cryptogenic hypertransaminasaemia","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"hep31065-bib-0164-20241017","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1590-8658(01)80014-1","article-title":"Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin","volume":"33","year":"2001","journal-title":"Dig Liver Dis"},{"key":"hep31065-bib-0165-20241017","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12016-008-8086-x","article-title":"Pathogenesis and clinical significance of liver injury in celiac disease","volume":"36","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"hep31065-bib-0166-20241017","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/MPG.0b013e31828b1dfa","article-title":"Celiac disease\u2013associated autoimmune hepatitis in childhood: long\u2010term response to treatment","volume":"56","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0167-20241017","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.dld.2015.11.013","article-title":"Celiac disease\u2013related hepatic injury: insights into associated conditions and underlying pathomechanisms","volume":"48","year":"2016","journal-title":"Dig Liver Dis"},{"key":"hep31065-bib-0168-20241017","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1034\/j.1600-0676.2000.020004340.x","article-title":"Sequential occurrence of primary sclerosing cholangitis and autoimmune hepatitis type III in a patient with ulcerative colitis: a follow up study over 14 years","volume":"20","year":"2000","journal-title":"Liver"},{"key":"hep31065-bib-0169-20241017","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.1840360615","article-title":"Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome","volume":"36","year":"2002","journal-title":"Hepatology"},{"key":"hep31065-bib-0170-20241017","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.21229","article-title":"Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis","volume":"44","year":"2006","journal-title":"Hepatology"},{"key":"hep31065-bib-0171-20241017","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1478-3231.2007.01538.x","article-title":"Development of autoimmune hepatitis in primary biliary cirrhosis","volume":"27","year":"2007","journal-title":"Liver Int"},{"key":"hep31065-bib-0172-20241017","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejim.2008.12.011","article-title":"Transitions between variant forms of primary biliary cirrhosis during long\u2010term follow\u2010up","volume":"20","year":"2009","journal-title":"Eur J Intern Med"},{"key":"hep31065-bib-0173-20241017","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2013.08.039","article-title":"Cholestatic phenotypes of autoimmune hepatitis","volume":"12","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0174-20241017","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","article-title":"The variant forms of autoimmune hepatitis","volume":"125","year":"1996","journal-title":"Ann Intern Med"},{"key":"hep31065-bib-0175-20241017","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","year":"1998","journal-title":"Hepatology"},{"key":"hep31065-bib-0176-20241017","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.gtc.2017.01.008","article-title":"Autoimmune hepatitis overlap syndromes and liver pathology","volume":"46","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"hep31065-bib-0177-20241017","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis\u2013autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","year":"1998","journal-title":"Hepatology"},{"key":"hep31065-bib-0178-20241017","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1440-1746.2006.04130.x","article-title":"Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial\/anti\u2010M2 seropositive variant form of autoimmune hepatitis","volume":"21","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"hep31065-bib-0179-20241017","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"hep31065-bib-0180-20241017","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.28140","article-title":"Changing nomenclature for PBC: from \u201ccirrhosis\u201d to \u201ccholangitis","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"hep31065-bib-0181-20241017","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cgh.2010.03.004","article-title":"Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome","volume":"8","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0182-20241017","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cgh.2011.03.019","article-title":"Prevalence of primary biliary cirrhosis\u2013autoimmune hepatitis overlap syndrome","volume":"9","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0183-20241017","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long\u2010term follow\u2010up of antimitochondrial antibody\u2013positive autoimmune hepatitis","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"hep31065-bib-0184-20241017","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid\u2010treated autoimmune hepatitis","volume":"14","year":"1992","journal-title":"J Hepatol"},{"key":"hep31065-bib-0185-20241017","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejim.2008.06.004","article-title":"High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis","volume":"20","year":"2009","journal-title":"Eur J Intern Med"},{"key":"hep31065-bib-0186-20241017","first-page":"154","article-title":"\u201cTrue\u201d antimitochondrial antibody\u2013negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?","volume":"135","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"hep31065-bib-0187-20241017","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug\u2010induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"hep31065-bib-0188-20241017","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug\u2010induced autoimmune\u2010like hepatitis","volume":"56","year":"2011","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0189-20241017","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s10620-011-1787-7","article-title":"Drug\u2010induced autoimmune\u2010like hepatitis: a diagnostic challenge","volume":"56","year":"2011","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0190-20241017","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0034-1375959","article-title":"Drug\u2010induced liver injury with autoimmune features","volume":"34","year":"2014","journal-title":"Semin Liver Dis"},{"key":"hep31065-bib-0191-20241017","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.dld.2014.08.040","article-title":"Clinical features and outcomes of patients with drug\u2010induced autoimmune hepatitis: a retrospective cohort study","volume":"46","year":"2014","journal-title":"Dig Liver Dis"},{"key":"hep31065-bib-0192-20241017","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/bmj.312.7024.169","article-title":"Minocycline induced autoimmune hepatitis and systemic lupus erythematosus\u2010like syndrome","volume":"312","year":"1996","journal-title":"BMJ"},{"key":"hep31065-bib-0193-20241017","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1023\/A:1018817926394","article-title":"Study of immune reactivity of minocycline\u2010induced chronic active hepatitis","volume":"42","year":"1997","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0194-20241017","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00004836-199807000-00016","article-title":"Minocycline\u2010induced hepatitis with autoimmune features and neutropenia","volume":"27","year":"1998","journal-title":"J Clin Gastroenterol"},{"key":"hep31065-bib-0195-20241017","first-page":"1132","article-title":"Minocycline\u2010related autoimmune hepatitis: case series and literature review","volume":"152","year":"1998","journal-title":"Arch Pediatr Adolesc Med"},{"key":"hep31065-bib-0196-20241017","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1309\/KV2J-VX6Q-L95V-VDE4","article-title":"Minocycline as a cause of drug\u2010induced autoimmune hepatitis. Report of four cases and comparison with autoimmune hepatitis","volume":"114","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"hep31065-bib-0197-20241017","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2169\/internalmedicine.42.48","article-title":"Drug\u2010induced hepatitis with autoimmune features during minocycline therapy","volume":"42","year":"2003","journal-title":"Intern Med"},{"key":"hep31065-bib-0198-20241017","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/MCG.0b013e31818c8801","article-title":"Long\u2010term minocycline use for acne in healthy adolescents can cause severe autoimmune hepatitis","volume":"43","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"hep31065-bib-0199-20241017","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0002-9343(79)90086-X","article-title":"Nitrofurantoin: another cause of drug\u2010induced chronic active hepatitis? A report of a patient with HLA\u2010B8 antigen","volume":"67","year":"1979","journal-title":"Am J Med"},{"key":"hep31065-bib-0200-20241017","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-92-1-14","article-title":"Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin","volume":"92","year":"1980","journal-title":"Ann Intern Med"},{"key":"hep31065-bib-0201-20241017","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840080327","article-title":"Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases","volume":"8","year":"1988","journal-title":"Hepatology"},{"key":"hep31065-bib-0202-20241017","first-page":"891","article-title":"Long\u2010term hepatic memory for hypersensitivity to nitrofurantoin","volume":"87","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0203-20241017","first-page":"184","article-title":"Nitrofurantoin\u2010induced chronic active hepatitis","volume":"4","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"hep31065-bib-0204-20241017","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.23696","article-title":"Standardization of nomenclature and causality assessment in drug\u2010induced liver injury: summary of a clinical research workshop","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"hep31065-bib-0205-20241017","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/1752-1947-4-311","article-title":"Autoimmune hepatitis triggered by nitrofurantoin: a case series","volume":"4","year":"2010","journal-title":"J Med Case Rep"},{"key":"hep31065-bib-0206-20241017","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/ard.2004.032821","article-title":"Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis","volume":"64","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"hep31065-bib-0207-20241017","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10067-005-0169-y","article-title":"Serious liver disease induced by infliximab","volume":"26","year":"2007","journal-title":"Clin Rheumatol"},{"key":"hep31065-bib-0208-20241017","doi-asserted-by":"crossref","first-page":"524","DOI":"10.5694\/j.1326-5377.2007.tb01396.x","article-title":"Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis","volume":"187","year":"2007","journal-title":"Med J Aust"},{"key":"hep31065-bib-0209-20241017","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ibd.20293","article-title":"Infliximab\u2010induced lupus\u2010like syndrome associated with autoimmune hepatitis","volume":"14","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"hep31065-bib-0210-20241017","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10067-009-1179-y","article-title":"Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept","volume":"28","year":"2009","journal-title":"Clin Rheumatol"},{"key":"hep31065-bib-0211-20241017","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2230.2008.03088.x","article-title":"Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriaisis","volume":"34","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"hep31065-bib-0212-20241017","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1002\/ibd.21880","article-title":"Infliximab\u2010induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate","volume":"17","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"hep31065-bib-0213-20241017","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1007\/s10620-011-1748-1","article-title":"Infliximab\u2010induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case","volume":"56","year":"2011","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0214-20241017","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug\u2010induced liver injury in the general population of Iceland","volume":"144","year":"2013","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0215-20241017","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.autrev.2012.03.010","article-title":"Drug induced autoimmune hepatitis and TNF\u2010alpha blocking agents: is there a real relationship?","volume":"12","year":"2013","journal-title":"Autoimmun Rev"},{"key":"hep31065-bib-0216-20241017","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cgh.2012.12.025","article-title":"Liver injury from tumor necrosis factor\u2010alpha antagonists: analysis of thirty\u2010four cases","volume":"11","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0217-20241017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/ajd.12054","article-title":"Drug\u2010induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis","volume":"55","year":"2014","journal-title":"Australas J Dermatol"},{"key":"hep31065-bib-0218-20241017","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.cgh.2014.07.062","article-title":"Risk of drug\u2010induced liver injury from tumor necrosis factor antagonists","volume":"13","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0219-20241017","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.3748\/wjg.v21.i24.7584","article-title":"Autoimmune hepatitis and anti\u2010tumor necrosis factor alpha therapy: a single center report of 8 cases","volume":"21","year":"2015","journal-title":"World J Gastroenterol"},{"key":"hep31065-bib-0220-20241017","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40264-015-0366-9","article-title":"Hepatotoxicity associated with the use of anti\u2010TNF\u2010alpha agents","volume":"39","year":"2016","journal-title":"Drug Saf"},{"key":"hep31065-bib-0221-20241017","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpeds.2017.10.071","article-title":"New onset autoimmune hepatitis during anti\u2013tumor necrosis factor\u2010alpha treatment in children","volume":"194","year":"2018","journal-title":"J Pediatr"},{"key":"hep31065-bib-0222-20241017","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1158\/2326-6066.CIR-18-0487","article-title":"The balancing act between cancer immunity and autoimmunity in response to immunotherapy","volume":"6","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"hep31065-bib-0223-20241017","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3747\/co.25.4235","article-title":"Immune\u2010related adverse events of immune checkpoint inhibitors: a brief review","volume":"25","year":"2018","journal-title":"Curr Oncol"},{"key":"hep31065-bib-0224-20241017","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/08916934.2019.1641200","article-title":"Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis","volume":"52","year":"2019","journal-title":"Autoimmunity"},{"key":"hep31065-bib-0225-20241017","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s10620-012-2140-5","article-title":"Pathologic changes in ipilimumab\u2010related hepatitis in patients with metastatic melanoma","volume":"57","year":"2012","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0226-20241017","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41424-018-0049-9","article-title":"Immune checkpoint inhibitor\u2010associated colits and hepatitis","volume":"9","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"hep31065-bib-0227-20241017","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1634\/theoncologist.2018-0174","article-title":"Diagnosis and management of hepatitis in patients on checkpoint blockade","volume":"23","year":"2018","journal-title":"Oncologist"},{"key":"hep31065-bib-0228-20241017","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s41379-018-0013-y","article-title":"Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug\u2010induced liver injury","volume":"31","year":"2018","journal-title":"Mod Pathol"},{"key":"hep31065-bib-0229-20241017","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12072-018-9921-7","article-title":"Liver damage related to immune checkpoint inhibitors","volume":"13","year":"2019","journal-title":"Hepatol Int"},{"key":"hep31065-bib-0230-20241017","article-title":"Severe steroid\u2010resistant anti\u2010PD1 T\u2010cell checkpoint inhibitor\u2013induced hepatotoxicity driven by biliary injury","volume":"2","year":"2017","journal-title":"ESMO Open"},{"key":"hep31065-bib-0232-20241017","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1089-3261(02)00025-9","article-title":"Immune\u2010mediated drug\u2010induced liver disease","volume":"6","year":"2002","journal-title":"Clin Liver Dis"},{"key":"hep31065-bib-0233-20241017","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/hep.21095","article-title":"Drug\u2010induced liver injury: summary of a single topic clinical research conference","volume":"43","year":"2006","journal-title":"Hepatology"},{"issue":"\u2010","key":"hep31065-bib-0234-20241017","first-page":"1340","article-title":"Features and outcomes of 899 patients with drug\u2010induced liver injury: the DILIN prospective study","volume":"148","year":"2015","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0235-20241017","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.2008.058248","article-title":"Histological patterns in drug\u2010induced liver disease","volume":"62","year":"2009","journal-title":"J Clin Pathol"},{"key":"hep31065-bib-0236-20241017","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug\u2010induced liver injury","volume":"15","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0237-20241017","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug\u2010induced liver injury","volume":"54","year":"2011","journal-title":"Hepatology"},{"key":"hep31065-bib-0238-20241017","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2036.2007.03355.x","article-title":"Long\u2010term follow\u2010up of patients with mild to moderate drug\u2010induced liver injury","volume":"26","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0239-20241017","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jhep.2008.10.021","article-title":"The long\u2010term follow\u2010up after idiosyncratic drug\u2010induced liver injury with jaundice","volume":"50","year":"2009","journal-title":"J Hepatol"},{"key":"hep31065-bib-0240-20241017","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug\u2010induced liver disease","volume":"42","year":"2005","journal-title":"Hepatology"},{"key":"hep31065-bib-0241-20241017","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug\u2010induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10\u2010year period","volume":"129","year":"2005","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0242-20241017","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/j.gastro.2014.03.050","article-title":"Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug\u2010induced liver injury","volume":"147","year":"2014","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0243-20241017","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1478-3231.2007.01444.x","article-title":"Consequences of treatment withdrawal in type 1 autoimmune hepatitis","volume":"27","year":"2007","journal-title":"Liver Int"},{"key":"hep31065-bib-0244-20241017","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","year":"2013","journal-title":"J Hepatol"},{"key":"hep31065-bib-0245-20241017","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4254\/wjh.v6.i4.160","article-title":"Drug\u2010induced autoimmune liver disease: a diagnostic dilemma of an increasingly reported disease","volume":"6","year":"2014","journal-title":"World J Hepatol"},{"key":"hep31065-bib-0246-20241017","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2014.03.045","article-title":"Idiosyncratic drug\u2010induced liver injury is associated with substantial morbidity and mortality within 6 months from onset","volume":"147","year":"2014","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0247-20241017","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1373\/clinchem.2006.070961","article-title":"A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C","volume":"52","year":"2006","journal-title":"Clin Chem"},{"key":"hep31065-bib-0248-20241017","first-page":"445","article-title":"Prognostic value of liver fibrosis biomarkers: a meta\u2010analysis","volume":"7","year":"2011","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"hep31065-bib-0249-20241017","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jhep.2011.08.007","article-title":"Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"hep31065-bib-0250-20241017","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","year":"2003","journal-title":"Hepatology"},{"key":"hep31065-bib-0251-20241017","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"hep31065-bib-0252-20241017","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0253-20241017","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/gut.2009.203166","article-title":"Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease","volume":"59","year":"2010","journal-title":"Gut"},{"key":"hep31065-bib-0254-20241017","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2893.2009.01263.x","article-title":"Enhanced liver fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C","volume":"18","year":"2011","journal-title":"J Viral Hepat"},{"key":"hep31065-bib-0255-20241017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0065-2423(08)00404-6","article-title":"Biomarkers of liver fibrosis","volume":"46","year":"2008","journal-title":"Adv Clin Chem"},{"key":"hep31065-bib-0256-20241017","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/apt.12592","article-title":"Review article: prevention and reversal of hepatic fibrosis in autoimmune hepatitis","volume":"39","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0257-20241017","first-page":"455","article-title":"Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers","volume":"47","year":"2008","journal-title":"Hepatology"},{"key":"hep31065-bib-0258-20241017","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.22517","article-title":"Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"hep31065-bib-0259-20241017","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12072-018-9907-5","article-title":"Systematic review: diagnostic accuracy of non\u2010invasive tests for staging liver fibrosis in autoimmune hepatitis","volume":"13","year":"2019","journal-title":"Hepatol Int"},{"key":"hep31065-bib-0260-20241017","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2016.05.023","article-title":"Transient elastography in autoimmune hepatitis: timing determines the impact of inflammation and fibrosis","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"hep31065-bib-0261-20241017","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/jgh.13508","article-title":"Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis","volume":"32","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"hep31065-bib-0262-20241017","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.12659\/MSM.907300","article-title":"Transient elastography (FibroScan) performs better than non\u2010invasive markers in assessing liver fibrosis and cirrhosis in autoimmune hepatitis patients","volume":"23","year":"2017","journal-title":"Med Sci Monit"},{"key":"hep31065-bib-0263-20241017","first-page":"592","article-title":"Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage","volume":"47","year":"2008","journal-title":"Hepatology"},{"key":"hep31065-bib-0264-20241017","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1478-3231.2008.01743.x","article-title":"Disproportionally high results of transient elastography in patients with autoimmune hepatitis","volume":"28","year":"2008","journal-title":"Liver Int"},{"key":"hep31065-bib-0265-20241017","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jhep.2017.11.020","article-title":"Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis","volume":"68","year":"2018","journal-title":"J Hepatol"},{"key":"hep31065-bib-0266-20241017","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.gastro.2008.03.076","article-title":"Magnetic resonance elastography for the noninvasive staging of liver fibrosis","volume":"135","year":"2008","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0267-20241017","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jmri.23731","article-title":"Magnetic resonance elastography of liver: technique, analysis, and clinical applications","volume":"37","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"hep31065-bib-0268-20241017","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.27362","article-title":"Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study","volume":"60","year":"2014","journal-title":"Hepatology"},{"key":"hep31065-bib-0269-20241017","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3748\/wjg.v23.i5.859","article-title":"Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis","volume":"23","year":"2017","journal-title":"World J Gastroenterol"},{"key":"hep31065-bib-0270-20241017","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2214\/AJR.07.3504","article-title":"Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension","volume":"193","year":"2009","journal-title":"Am J Roentgenol"},{"key":"hep31065-bib-0271-20241017","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1148\/radiol.14132592","article-title":"MR elastography for the assessment of hepatic fibrosis in patients with chronic hepatitis B infection: does histologic necroinflammation influence the measurement of hepatic stiffness?","volume":"273","year":"2014","journal-title":"Radiology"},{"key":"hep31065-bib-0272-20241017","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.3748\/wjg.v19.i30.4841","article-title":"Acoustic radiation force impulse of the liver","volume":"19","year":"2013","journal-title":"World J Gastroenterol"},{"key":"hep31065-bib-0273-20241017","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13244-016-0514-5","article-title":"ARFI: from basic principles to clinical applications in diffuse chronic disease\u2010a review","volume":"7","year":"2016","journal-title":"Insights Imaging"},{"key":"hep31065-bib-0274-20241017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0029-1245948","article-title":"Accuracy of VirtualTouch acoustic radiation force impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography","volume":"32","year":"2011","journal-title":"Ultraschall Med"},{"key":"hep31065-bib-0275-20241017","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/liv.12240","article-title":"Meta\u2010analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis","volume":"33","year":"2013","journal-title":"Liver Int"},{"key":"hep31065-bib-0276-20241017","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.7863\/jum.2012.31.8.1245","article-title":"Liver and spleen stiffness measured by acoustic radiation force impulse elastography for noninvasive assessment of liver fibrosis and esophageal varices in patients with chronic hepatitis B","volume":"31","year":"2012","journal-title":"J Ultrasound Med"},{"key":"hep31065-bib-0277-20241017","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00535-013-0877-z","article-title":"Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high\u2010risk esophageal varices among patients with HCV\u2010related cirrhosis","volume":"49","year":"2014","journal-title":"J Gastroenterol"},{"key":"hep31065-bib-0278-20241017","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1055\/s-0029-1245690","article-title":"Acoustic radiation force impulse (ARFI) elastography in acute liver failure: necrosis mimics cirrhosis","volume":"49","year":"2011","journal-title":"Z Gastroenterol"},{"key":"hep31065-bib-0279-20241017","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archinte.1981.00340020085022","article-title":"Azathioprine\u2010induced pancytopenia. Occurrence in two patients with connective\u2010tissue diseases","volume":"141","year":"1981","journal-title":"Arch Intern Med"},{"key":"hep31065-bib-0280-20241017","first-page":"351","article-title":"Azathioprine\u2010induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis","volume":"23","year":"1995","journal-title":"J Hepatol"},{"key":"hep31065-bib-0281-20241017","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00008571-199208000-00002","article-title":"Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver\u2010erythrocyte correlation and presence of isozymes","volume":"2","year":"1992","journal-title":"Pharmacogenetics"},{"key":"hep31065-bib-0282-20241017","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0009-9236(97)90152-1","article-title":"Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms","volume":"62","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"hep31065-bib-0283-20241017","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7326\/0003-4819-126-8-199704150-00003","article-title":"Molecular diagnosis of thiopurine S\u2010methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance","volume":"126","year":"1997","journal-title":"Ann Intern Med"},{"key":"hep31065-bib-0284-20241017","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00228-008-0478-6","article-title":"Clinical pharmacology and pharmacogenetics of thiopurines","volume":"64","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"hep31065-bib-0285-20241017","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004836-200209000-00008","article-title":"Determination of thiopurine methyltransferase genotype or phenotype optimizes initial dosing of azathioprine for the treatment of Crohn's disease","volume":"35","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"hep31065-bib-0286-20241017","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1053\/j.gastro.2004.09.061","article-title":"Use of laboratory testing to guide 6\u2010mercaptopurine\/azathioprine therapy","volume":"127","year":"2004","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0287-20241017","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10245330701283959","article-title":"Should we test TPMT enzyme levels before starting azathioprine?","volume":"12","year":"2007","journal-title":"Hematology"},{"key":"hep31065-bib-0288-20241017","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/apt.12381","article-title":"Review article: the management of autoimmune hepatitis beyond consensus guidelines","volume":"38","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0289-20241017","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0168-8278(02)00214-3","article-title":"Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis","volume":"37","year":"2002","journal-title":"J Hepatol"},{"key":"hep31065-bib-0290-20241017","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2006.05.011","article-title":"Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis","volume":"45","year":"2006","journal-title":"J Hepatol"},{"key":"hep31065-bib-0291-20241017","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s10620-006-9336-5","article-title":"Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis","volume":"51","year":"2006","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0292-20241017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1155\/2011\/137476","article-title":"Azathioprine metabolite measurements are not useful in following treatment of autoimmune hepatitis in Alaska native and other non\u2010Caucasian people","volume":"25","year":"2011","journal-title":"Can J Gastroenterol"},{"key":"hep31065-bib-0294-20241017","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1572-0241.2007.01609.x","article-title":"Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases","volume":"103","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0295-20241017","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","year":"2019","journal-title":"Clin Transplant"},{"key":"hep31065-bib-0296-20241017","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.gastro.2014.10.038","article-title":"American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","year":"2015","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0297-20241017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.gastro.2014.10.039","article-title":"American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","year":"2015","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0298-20241017","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions","volume":"152","year":"2017","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0299-20241017","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"hep31065-bib-0300-20241017","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3350\/cmh.2016.0024","article-title":"Prevention of hepatitis B reactivation in the setting of immunosuppression","volume":"22","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"hep31065-bib-0301-20241017","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0016-5085(03)01060-6","article-title":"American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders","volume":"125","year":"2003","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0303-20241017","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1572-0241.2006.00571.x","article-title":"Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria","volume":"101","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0304-20241017","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s10620-010-1130-8","article-title":"Bone health in a tertiary\u2010care gastroenterology and hepatology population","volume":"55","year":"2010","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0305-20241017","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1007\/s10620-014-3267-3","article-title":"Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis","volume":"59","year":"2014","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0306-20241017","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/apt.15029","article-title":"Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis","volume":"49","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0307-20241017","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s10620-018-5351-6","article-title":"Evolving role of vitamin D in immune\u2010mediated disease and its implications in autoimmune hepatitis","volume":"64","year":"2019","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0308-20241017","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jhep.2006.06.007","article-title":"Treatment of bone disorders in liver disease","volume":"45","year":"2006","journal-title":"J Hepatol"},{"key":"hep31065-bib-0309-20241017","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/hep.21852","article-title":"Bone disorders in chronic liver disease","volume":"46","year":"2007","journal-title":"Hepatology"},{"key":"hep31065-bib-0310-20241017","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","year":"2009","journal-title":"Circulation"},{"key":"hep31065-bib-0311-20241017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: pathophysiology, management, and modulation by natural compounds","volume":"11","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"hep31065-bib-0312-20241017","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jhep.2012.09.002","article-title":"Treatment adherence\u2014room for improvement, not only in autoimmune hepatitis","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"hep31065-bib-0313-20241017","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/00042737-200412000-00028","article-title":"Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis","volume":"16","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep31065-bib-0314-20241017","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jhep.2012.07.032","article-title":"Identifying opportunities to improve management of autoimmune hepatitis: evaluation of drug adherence and psychosocial factors","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"hep31065-bib-0315-20241017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/liv.13960","article-title":"Autoimmune hepatitis exerts a profound, negative effect on health\u2010related quality of life: a prospective, single\u2010centre study","volume":"39","year":"2019","journal-title":"Liver Int"},{"key":"hep31065-bib-0316-20241017","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2013.10.035","article-title":"Health\u2010related quality of life, depression, and anxiety in patients with autoimmune hepatitis","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"hep31065-bib-0317-20241017","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"hep31065-bib-0318-20241017","article-title":"Health\u2010related quality of life in patients with autoimmune hepatitis: a questionnaire survey","volume":"13","year":"2018","journal-title":"PLoS One"},{"key":"hep31065-bib-0319-20241017","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/MPG.0b013e31829ef82c","article-title":"Health\u2010related quality of life in children with autoimmune liver disease","volume":"57","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0320-20241017","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/MPG.0000000000001930","article-title":"Autoimmune hepatitis in children and adolescents: effect on quality of life","volume":"66","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0321-20241017","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/hep.30031","article-title":"The impact of autoimmune hepatitis and its treatment on health utility","volume":"68","year":"2018","journal-title":"Hepatology"},{"key":"hep31065-bib-0322-20241017","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jped.2017.10.013","article-title":"Decreased health\u2010related quality of life in children and adolescents with autoimmune hepatitis","volume":"95","year":"2019","journal-title":"J Pediatr (Rio J)"},{"key":"hep31065-bib-0323-20241017","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1478-3231.2010.02333.x","article-title":"Psychological stress is associated with relapse in type 1 autoimmune hepatitis","volume":"30","year":"2010","journal-title":"Liver Int"},{"key":"hep31065-bib-0324-20241017","doi-asserted-by":"crossref","first-page":"J239","DOI":"10.1016\/j.jaut.2011.12.002","article-title":"Outcomes of pregnancy in women with autoimmune hepatitis","volume":"38","year":"2012","journal-title":"J Autoimmun"},{"key":"hep31065-bib-0325-20241017","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MCG.0b013e318176b8c5","article-title":"Follow\u2010up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes","volume":"43","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"hep31065-bib-0326-20241017","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1572-0241.2006.00479.x","article-title":"Pregnancy in autoimmune hepatitis: outcome and risk factors","volume":"101","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0327-20241017","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1111\/j.1572-0241.2002.07124.x","article-title":"Improvement of autoimmune hepatitis during pregnancy followed by flare\u2010up after delivery","volume":"97","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0328-20241017","first-page":"113","article-title":"Leber, Blutproteine und Nahrungseiweiss","volume":"15","year":"1950","journal-title":"Dtsch Gesellsch Verdau Stoffwechselkr"},{"key":"hep31065-bib-0329-20241017","first-page":"313","article-title":"Preimplantation factor (PIF) orchestrates systemic antiinflammatory response by immune cells: effect on peripheral blood mononuclear cells","volume":"207","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"hep31065-bib-0330-20241017","article-title":"Insight into preimplantation factor (PIF*) mechanism for embryo protection and development: target oxidative stress and protein misfolding (PDI and HSP) through essential RIKP [corrected] binding site","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"hep31065-bib-0331-20241017","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ajg.2015.430","article-title":"ACG clinical guideline: liver disease and pregnancy","volume":"111","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0333-20241017","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0002-9378(67)90503-0","article-title":"Azathioprine (Imuran) and pregnancy","volume":"97","year":"1967","journal-title":"Am J Obstet Gynecol"},{"key":"hep31065-bib-0334-20241017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ibd.22948","article-title":"Systematic review and meta\u2010analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease","volume":"19","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"hep31065-bib-0335-20241017","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1572-0241.2006.00538.x","article-title":"Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites","volume":"101","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0336-20241017","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-0035-1556743","article-title":"Update on the teratogenicity of maternal mycophenolate mofetil","volume":"4","year":"2015","journal-title":"J Pediatr Genet"},{"key":"hep31065-bib-0337-20241017","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpgasthep0768","article-title":"Current therapy for autoimmune hepatitis","volume":"4","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"hep31065-bib-0338-20241017","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1572-0241.2007.01153.x","article-title":"Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse","volume":"102","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0339-20241017","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0272-6386(81)80023-6","article-title":"Comparison of daily and alternate\u2010day prednisone during chronic maintenance therapy: a controlled crossover study","volume":"1","year":"1981","journal-title":"Am J Kidney Dis"},{"key":"hep31065-bib-0340-20241017","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","article-title":"Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared","volume":"16","year":"1975","journal-title":"Gut"},{"key":"hep31065-bib-0341-20241017","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14740338.7.3.319","article-title":"Safety issues in the management of autoimmune hepatitis","volume":"7","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"hep31065-bib-0342-20241017","first-page":"391","article-title":"Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report","volume":"35","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0343-20241017","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/FTD.0b013e3181dbd712","article-title":"Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis","volume":"32","year":"2010","journal-title":"Ther Drug Monit"},{"key":"hep31065-bib-0344-20241017","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jhep.2009.10.004","article-title":"Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis","volume":"52","year":"2010","journal-title":"J Hepatol"},{"key":"hep31065-bib-0345-20241017","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MPG.0000000000001563","article-title":"Outcomes in pediatric autoimmune hepatitis and significance of azathioprine metabolites","volume":"65","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0346-20241017","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1399-3046.2004.00230.x","article-title":"Utility of azathioprine metabolite measurements in post\u2010transplant recurrent autoimmune and immune\u2010mediated hepatitis","volume":"8","year":"2004","journal-title":"Pediatr Transplant"},{"key":"hep31065-bib-0347-20241017","doi-asserted-by":"crossref","first-page":"e844","DOI":"10.1542\/peds.2009-0415","article-title":"Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging","volume":"124","year":"2009","journal-title":"Pediatrics"},{"key":"hep31065-bib-0348-20241017","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.mpg.0000239735.87111.ba","article-title":"Prospective analysis of nonadherence in autoimmune hepatitis: a common problem","volume":"43","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0349-20241017","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature","volume":"9","year":"2018","journal-title":"Nat Commun"},{"key":"hep31065-bib-0350-20241017","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","year":"2010","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0351-20241017","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cgh.2017.11.003","article-title":"Budesonide in autoimmune hepatitis: the right drug at the right time for the right patient","volume":"16","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0352-20241017","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1053\/gast.2000.0010000001","article-title":"Failure of budesonide in a pilot study of treatment\u2010dependent autoimmune hepatitis","volume":"119","year":"2000","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0353-20241017","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3748\/wjg.v9.i12.2681","article-title":"Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC","volume":"9","year":"2003","journal-title":"World J Gastroenterol"},{"key":"hep31065-bib-0354-20241017","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.autrev.2011.09.006","article-title":"Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome","volume":"11","year":"2012","journal-title":"Autoimmun Rev"},{"key":"hep31065-bib-0355-20241017","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/jhep.2003.50266","article-title":"Pharmacokinetics and pharmacodynamic action of budesonide in early\u2010 and late\u2010stage primary biliary cirrhosis","volume":"38","year":"2003","journal-title":"Hepatology"},{"key":"hep31065-bib-0356-20241017","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cgh.2016.12.040","article-title":"Efficacy and limitations of budesonide as a second\u2010line treatment for patients with autoimmune hepatitis","volume":"16","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0357-20241017","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jpeds.2013.05.042","article-title":"Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents","volume":"163","year":"2013","journal-title":"J Pediatr"},{"key":"hep31065-bib-0358-20241017","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/apt.14968","article-title":"Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom","volume":"48","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0359-20241017","first-page":"55","article-title":"Prospective survey of health and socioeconomical characteristics of 249 patients with autoimmune hepatitis","volume":"31","year":"2013","journal-title":"Verdauungskrankheiten"},{"key":"hep31065-bib-0360-20241017","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment\u2010naive patients","volume":"55","year":"2011","journal-title":"J Hepatol"},{"key":"hep31065-bib-0361-20241017","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/apt.13584","article-title":"A real\u2010world study focused on the long\u2010term efficacy of mycophenolate mofetil as first\u2010line treatment of autoimmune hepatitis","volume":"43","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0362-20241017","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/MEG.0000000000001367","article-title":"Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta\u2010analysis","volume":"31","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep31065-bib-0363-20241017","first-page":"771","article-title":"Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open\u2010label preliminary trial","volume":"90","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0364-20241017","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(99)80065-8","article-title":"Short\u2010term cyclosporine induces a remission of autoimmune hepatitis in children","volume":"30","year":"1999","journal-title":"J Hepatol"},{"key":"hep31065-bib-0365-20241017","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1010683817344","article-title":"Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis","volume":"46","year":"2001","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0366-20241017","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1651-2227.2012.02745.x","article-title":"Tacrolimus without or with the addition of conventional immunosuppressive treatment in juvenile autoimmune hepatitis","volume":"101","year":"2012","journal-title":"Acta Paediatr"},{"key":"hep31065-bib-0367-20241017","first-page":"193","article-title":"Cyclosporine\u2010A versus prednisolone for induction of remission in auto\u2010immune hepatitis: interim analysis report of a randomized controlled trial","volume":"5","year":"2013","journal-title":"Middle East J Dig Dis"},{"key":"hep31065-bib-0368-20241017","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.dld.2018.10.018","article-title":"Long\u2010term follow\u2010up of children and young adults with autoimmune hepatitis treated with cyclosporine","volume":"51","year":"2019","journal-title":"Dig Liver Dis"},{"key":"hep31065-bib-0369-20241017","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.mpg.0000235975.75120.38","article-title":"Follow\u2010up of children with autoimmune hepatitis treated with cyclosporine","volume":"43","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0370-20241017","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jhep.2014.05.021","article-title":"Prognosis of acute severe autoimmune hepatitis (AS\u2010AIH): the role of corticosteroids in modifying outcome","volume":"61","year":"2014","journal-title":"J Hepatol"},{"key":"hep31065-bib-0371-20241017","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/hep.26678","article-title":"Steroid use in acute liver failure","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"hep31065-bib-0372-20241017","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/lt.21036","article-title":"Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis","volume":"13","year":"2007","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0373-20241017","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/lt.21088","article-title":"Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation","volume":"13","year":"2007","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0374-20241017","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/lt.25451","article-title":"Acute severe sutoimmune hepatitis: corticosteroids or liver transplantation?","volume":"25","year":"2019","journal-title":"Liver Transpl"},{"issue":"Suppl. 1","key":"hep31065-bib-0375-20241017","first-page":"S14","article-title":"Clinical epidemiology of fulminant hepatitis in Japan","volume":"38","year":"2008","journal-title":"Hepatol Res"},{"key":"hep31065-bib-0376-20241017","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.24141","article-title":"Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"hep31065-bib-0377-20241017","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00535-012-0624-x","article-title":"Acute liver failure in Japan: definition, classification, and prediction of the outcome","volume":"47","year":"2012","journal-title":"J Gastroenterol"},{"key":"hep31065-bib-0378-20241017","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0016-5085(88)90503-3","article-title":"Features reflective of early prognosis in corticosteroid\u2010treated severe autoimmune chronic active hepatitis","volume":"95","year":"1988","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0379-20241017","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jhep.2009.02.026","article-title":"Rapidity of treatment response and outcome in type 1 autoimmune hepatitis","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"hep31065-bib-0380-20241017","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/apt.12563","article-title":"Systematic review with meta\u2010analysis: clinical manifestations and management of autoimmune hepatitis in the elderly","volume":"39","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0381-20241017","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.26666","article-title":"Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"hep31065-bib-0382-20241017","article-title":"Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis","volume":"12","year":"2017","journal-title":"PLoS One"},{"key":"hep31065-bib-0383-20241017","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/MEG.0000000000000355","article-title":"Angiotensin\u2010converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitis","volume":"27","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep31065-bib-0384-20241017","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"hep31065-bib-0385-20241017","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2014.10.018","article-title":"Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis","volume":"62","year":"2015","journal-title":"J Hepatol"},{"key":"hep31065-bib-0386-20241017","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.1840040409","article-title":"Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg\u2010negative chronic active hepatitis","volume":"4","year":"1984","journal-title":"Hepatology"},{"key":"hep31065-bib-0387-20241017","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/jhep.2002.32485","article-title":"Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis","volume":"35","year":"2002","journal-title":"Hepatology"},{"key":"hep31065-bib-0388-20241017","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1600-0676.2003.00810.x","article-title":"Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis","volume":"23","year":"2003","journal-title":"Liver Int"},{"key":"hep31065-bib-0389-20241017","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/gastro\/goy020","article-title":"Well\u2010controlled autoimmune hepatitis treatment withdrawal may be safely accomplished without liver\u2010biopsy guidance","volume":"6","year":"2018","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"hep31065-bib-0390-20241017","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s10620-010-1243-0","article-title":"Late relapse of type 1 autoimmune hepatitis after corticosteroid withdrawal","volume":"55","year":"2010","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0391-20241017","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/apt.12701","article-title":"Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis","volume":"39","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0392-20241017","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jpeds.2013.12.008","article-title":"Outcome after discontinuation of immunosuppression in children with autoimmune hepatitis: a population\u2010based study","volume":"164","year":"2014","journal-title":"J Pediatr"},{"key":"hep31065-bib-0393-20241017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0016-5085(87)90862-6","article-title":"Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen\u2013negative chronic active hepatitis","volume":"92","year":"1987","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0394-20241017","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0016-5085(80)90866-5","article-title":"Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid\u2010induced remission","volume":"78","year":"1980","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0395-20241017","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.1840030510","article-title":"Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis","volume":"3","year":"1983","journal-title":"Hepatology"},{"key":"hep31065-bib-0396-20241017","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/hep.25760","article-title":"Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis","volume":"56","year":"2012","journal-title":"Hepatology"},{"key":"hep31065-bib-0397-20241017","first-page":"668","article-title":"Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis","volume":"1","year":"1985","journal-title":"Lancet"},{"key":"hep31065-bib-0398-20241017","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","article-title":"Azathioprine for long\u2010term maintenance of remission in autoimmune hepatitis","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"hep31065-bib-0399-20241017","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/liv.14051","article-title":"Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): is it justified (and in whom and when)?","volume":"39","year":"2019","journal-title":"Liver Int"},{"key":"hep31065-bib-0400-20241017","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.1840110621","article-title":"Low\u2010dose corticosteroid therapy after multiple relapses of severe HBsAg\u2010negative chronic active hepatitis","volume":"11","year":"1990","journal-title":"Hepatology"},{"key":"hep31065-bib-0401-20241017","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1478-3231.2005.01141.x","article-title":"Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy","volume":"25","year":"2005","journal-title":"Liver Int"},{"key":"hep31065-bib-0402-20241017","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/1756283X12450251","article-title":"Management of patients with difficult autoimmune hepatitis","volume":"5","year":"2012","journal-title":"Ther Adv Gastroenterol"},{"key":"hep31065-bib-0403-20241017","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/apt.12042","article-title":"Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs","volume":"36","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0404-20241017","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1155\/2004\/504591","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy","volume":"18","year":"2004","journal-title":"Can J Gastroenterol"},{"key":"hep31065-bib-0405-20241017","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2009.02.024","article-title":"Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5\u2010year follow\u2010up","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"hep31065-bib-0406-20241017","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cgh.2007.02.030","article-title":"Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy","volume":"5","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0407-20241017","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cgh.2008.04.006","article-title":"A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis","volume":"6","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0408-20241017","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0409-20241017","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2036.2011.04727.x","article-title":"The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes","volume":"34","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0410-20241017","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1586\/egh.11.45","article-title":"Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy","volume":"5","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"hep31065-bib-0411-20241017","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/0016-5085(87)90454-9","article-title":"Cyclosporine treatment of autoimmune chronic active hepatitis","volume":"93","year":"1987","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0412-20241017","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00004836-199312000-00012","article-title":"A case of cyclosporine\u2010sensitive, steroid\u2010resistant, autoimmune chronic active hepatitis","volume":"17","year":"1993","journal-title":"J Clin Gastroenterol"},{"key":"hep31065-bib-0413-20241017","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0168-8278(05)80615-4","article-title":"Cyclosporine in the management of corticosteroid\u2010resistant type I autoimmune chronic active hepatitis","volume":"21","year":"1994","journal-title":"J Hepatol"},{"key":"hep31065-bib-0414-20241017","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/gut.36.3.459","article-title":"Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis","volume":"36","year":"1995","journal-title":"Gut"},{"key":"hep31065-bib-0415-20241017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3476(99)70339-2","article-title":"Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis","volume":"135","year":"1999","journal-title":"J Pediatr"},{"key":"hep31065-bib-0416-20241017","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MPG.0000000000001530","article-title":"Second\u2010line agents in pediatric patients with autoimmune hepatitis: a systematic review and meta\u2010analysis","volume":"65","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0417-20241017","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.mcg.0000139050.67178.be","article-title":"Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis","volume":"38","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"hep31065-bib-0418-20241017","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.cgh.2017.06.001","article-title":"Efficacy and safety of mycophenolate mofetil and tacrolimus as second\u2010line therapy for patients with autoimmune hepatitis","volume":"15","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0419-20241017","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s10620-018-5011-x","article-title":"Tacrolimus and mycophenolate mofetil as second\u2010line therapies for pediatric patients with autoimmune hepatitis","volume":"63","year":"2018","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0420-20241017","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/00365521.2015.1095351","article-title":"Long\u2010term follow\u2010up of patients with difficult to treat type 1 autoimmune hepatitis on tacrolimus therapy","volume":"51","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"hep31065-bib-0421-20241017","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/gast.1996.v110.pm8536867","article-title":"The successful treatment of autoimmune hepatitis with 6\u2010mercaptopurine after failure with azathioprine","volume":"110","year":"1996","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0422-20241017","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cgh.2015.09.037","article-title":"Efficacy of 6\u2010mercaptopurine as second\u2010line treatment for patients with autoimmune hepatitis and azathioprine intolerance","volume":"14","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0423-20241017","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2013\/512624","article-title":"Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy","volume":"27","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"hep31065-bib-0424-20241017","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult\u2010to\u2010treat autoimmune hepatitis","volume":"58","year":"2013","journal-title":"J Hepatol"},{"key":"hep31065-bib-0425-20241017","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/apt.15157","article-title":"Systematic review with meta\u2010analysis: mycophenolate mofetil as a second\u2010line therapy for autoimmune hepatitis","volume":"49","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0426-20241017","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MEG.0000000000001019","article-title":"A systematic review and meta\u2010analysis of second\u2010line immunosuppressants for autoimmune hepatitis treatment","volume":"30","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep31065-bib-0427-20241017","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/apt.15248","article-title":"Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis, who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels","volume":"49","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0428-20241017","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2036.2011.04749.x","article-title":"Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience","volume":"34","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0429-20241017","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/00365521.2018.1551498","article-title":"A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis","volume":"54","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"hep31065-bib-0430-20241017","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1478-3231.2005.01107.x","article-title":"Transplant immunosuppressive agents in non\u2010transplant chronic autoimmune hepatitis: the Canadian Association for the Study of Liver (CASL) experience with mycophenolate mofetil and tacrolimus","volume":"25","year":"2005","journal-title":"Liver Int"},{"issue":"Suppl. 1","key":"hep31065-bib-0431-20241017","first-page":"25","article-title":"Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab","volume":"24","year":"2010","journal-title":"BioDrugs"},{"key":"hep31065-bib-0432-20241017","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10067-008-0885-1","article-title":"A case of autoimmune hepatitis exacerbated by the administration of etanercept in the patient with rheumatoid arthritis","volume":"27","year":"2008","journal-title":"Clin Rheumatol"},{"key":"hep31065-bib-0433-20241017","first-page":"402","article-title":"Role of biologics in the development of autoimmune hepatitis: a review","volume":"6","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"hep31065-bib-0434-20241017","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/MPG.0000000000001759","article-title":"Anti\u2010TNFalpha treatment in children and adolescents with combined inflammatory bowel disease and autoimmune liver disease","volume":"66","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0435-20241017","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1542\/peds.2011-1900","article-title":"Successful treatment of refractory autoimmune hepatitis with rituximab","volume":"132","year":"2013","journal-title":"Pediatrics"},{"key":"hep31065-bib-0436-20241017","first-page":"400","article-title":"The pharmacology of azathioprine","volume":"685","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"hep31065-bib-0437-20241017","first-page":"601","article-title":"Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase","volume":"29","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"hep31065-bib-0438-20241017","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cgh.2017.07.032","article-title":"Safety and efficacy of 6\u2010thioguanine as a second\u2010line treatment for autoimmune hepatitis","volume":"16","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0439-20241017","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/apt.14939","article-title":"Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands","volume":"48","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0440-20241017","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00042737-200504000-00012","article-title":"Promising treatment of autoimmune hepatitis with 6\u2010thioguanine after adverse events on azathioprine","volume":"17","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep31065-bib-0441-20241017","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0016-5085(03)00938-7","article-title":"6\u2010Thioguanine can cause serious liver injury in inflammatory bowel disease patients","volume":"125","year":"2003","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0442-20241017","first-page":"291","article-title":"Dosing 6\u2010thioguanine in inflammatory bowel disease: expert\u2010based guidelines for daily practice","volume":"19","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"key":"hep31065-bib-0443-20241017","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2036.2012.05223.x","article-title":"Review article: overlap syndromes and autoimmune liver disease","volume":"36","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0444-20241017","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","article-title":"Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid","volume":"35","year":"2002","journal-title":"Hepatology"},{"key":"hep31065-bib-0445-20241017","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.1998.224_a.x","article-title":"Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases","volume":"93","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0446-20241017","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","year":"1999","journal-title":"Hepatology"},{"key":"hep31065-bib-0447-20241017","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0448-20241017","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"hep31065-bib-0449-20241017","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long\u2010term outcome and survival","volume":"28","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0450-20241017","first-page":"326","article-title":"The overlap syndromes of autoimmune hepatitis","volume":"58","year":"2013","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0451-20241017","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1053\/j.gastro.2011.02.065","article-title":"Long\u2010term outcomes of patients with autoimmune hepatitis managed at a nontransplant center","volume":"140","year":"2011","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0452-20241017","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/hep.21884","article-title":"The impact of ethnicity on the natural history of autoimmune hepatitis","volume":"46","year":"2007","journal-title":"Hepatology"},{"key":"hep31065-bib-0453-20241017","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MCG.0b013e318228b781","article-title":"The impact of race\/ethnicity on the clinical epidemiology of autoimmune hepatitis","volume":"46","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"hep31065-bib-0454-20241017","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","article-title":"Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end\u2010stage liver disease","volume":"46","year":"2007","journal-title":"Hepatology"},{"key":"hep31065-bib-0455-20241017","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00002512-200825030-00005","article-title":"Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly","volume":"25","year":"2008","journal-title":"Drugs Aging"},{"key":"hep31065-bib-0456-20241017","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/egh.13.21","article-title":"Autoimmune hepatitis in diverse ethnic populations and geographical regions","volume":"7","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"hep31065-bib-0457-20241017","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/j.1572-0241.2001.05272.x","article-title":"Autoimmune hepatitis in African Americans: presenting features and response to therapy","volume":"96","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0458-20241017","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/ajg.2017.456","article-title":"Hospitalizations for autoimmune hepatitis disproportionately affect black and Latino Americans","volume":"113","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0459-20241017","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.cgh.2018.11.028","article-title":"Association between black race and presentation and liver\u2010related outcomes of patients with autoimmune hepatitis","volume":"17","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0460-20241017","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10620-010-1444-6","article-title":"Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series","volume":"56","year":"2011","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0461-20241017","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10620-012-2525-5","article-title":"Hepatocellular cancer and other malignancies in autoimmune hepatitis","volume":"58","year":"2013","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0462-20241017","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jhep.2008.08.022","article-title":"Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long\u2010term follow\u2010up in 473 Swedish patients","volume":"50","year":"2009","journal-title":"J Hepatol"},{"key":"hep31065-bib-0463-20241017","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.24743","article-title":"Mortality and the risk of malignancy in autoimmune liver diseases: a population\u2010based study in Canterbury, New Zealand","volume":"55","year":"2012","journal-title":"Hepatology"},{"key":"hep31065-bib-0464-20241017","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.1840100110","article-title":"Extrahepatic malignancy following long\u2010term immunosuppressive therapy of severe hepatitis B surface antigen\u2013negative chronic active hepatitis","volume":"10","year":"1989","journal-title":"Hepatology"},{"key":"hep31065-bib-0465-20241017","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1007\/s10620-010-1145-1","article-title":"Risk of non\u2010melanoma skin cancer in autoimmune hepatitis","volume":"55","year":"2010","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0466-20241017","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2009.04014.x","article-title":"Meta\u2010analysis: surveillance with ultrasound for early\u2010stage hepatocellular carcinoma in patients with cirrhosis","volume":"30","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0467-20241017","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","year":"2011","journal-title":"Gut"},{"key":"hep31065-bib-0468-20241017","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","year":"2018","journal-title":"Hepatology"},{"key":"hep31065-bib-0469-20241017","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"hep31065-bib-0470-20241017","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"hep31065-bib-0471-20241017","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cld.2011.08.008","article-title":"Recurrent and de novo autoimmune liver diseases","volume":"15","year":"2011","journal-title":"Clin Liver Dis"},{"key":"hep31065-bib-0472-20241017","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cgh.2017.09.062","article-title":"Twenty\u2010year comparative analysis of patients with autoimmune liver diseases on transplant waitlists","volume":"16","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0473-20241017","first-page":"e83","article-title":"Liver transplantation for children with primary sclerosing cholangitis and autoimmune hepatitis: UNOS database analysis","volume":"64","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0474-20241017","first-page":"315","article-title":"An analysis of the OPTN\/UNOS Liver Transplant Registry","year":"2004","journal-title":"Clin Transpl"},{"key":"hep31065-bib-0475-20241017","first-page":"461","article-title":"Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry","volume":"16","year":"2010","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0476-20241017","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.surg.2018.04.039","article-title":"Early mortality after liver transplantation: defining the course and the cause","volume":"164","year":"2018","journal-title":"Surgery"},{"key":"hep31065-bib-0477-20241017","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/lt.500040313","article-title":"Allograft rejection after liver transplantation for autoimmune liver diseases","volume":"4","year":"1998","journal-title":"Liver Transpl Surg"},{"key":"hep31065-bib-0478-20241017","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00007890-200008150-00014","article-title":"Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors","volume":"70","year":"2000","journal-title":"Transplantation"},{"key":"hep31065-bib-0479-20241017","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/TP.0b013e3182845f6c","article-title":"Late acute liver allograft rejection; a study of its natural history and graft survival in the current era","volume":"95","year":"2013","journal-title":"Transplantation"},{"key":"hep31065-bib-0480-20241017","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0012.2004.00117.x","article-title":"Long\u2010term outcome of liver transplantation for autoimmune hepatitis","volume":"18","year":"2004","journal-title":"Clin Transplant"},{"key":"hep31065-bib-0481-20241017","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00007890-200104270-00016","article-title":"Reasons for long\u2010term use of steroid in primary adult liver transplantation under tacrolimus","volume":"71","year":"2001","journal-title":"Transplantation"},{"key":"hep31065-bib-0482-20241017","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1477-2574.2012.00576.x","article-title":"A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow\u2010up of over 7 years","volume":"15","year":"2013","journal-title":"HPB (Oxford)"},{"key":"hep31065-bib-0483-20241017","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","year":"2016","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0484-20241017","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/lt.25205","article-title":"Con: steroids should not be withdrawn in transplant recipients with autoimmune hepatitis","volume":"24","year":"2018","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0485-20241017","first-page":"S48","article-title":"Early steroid withdrawal in liver transplantation is safe and beneficial","volume":"5(Suppl. 1)","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"hep31065-bib-0486-20241017","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/lt.500050514","article-title":"Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis","volume":"5","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"hep31065-bib-0487-20241017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/152692480101100312","article-title":"Steroid withdrawal in liver transplant recipients","volume":"11","year":"2001","journal-title":"Prog Transplant"},{"key":"hep31065-bib-0488-20241017","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/S0041-1345(02)03570-4","article-title":"Autoimmune hepatitis following liver transplantation: relationship to recurrent disease and steroid weaning","volume":"34","year":"2002","journal-title":"Transplant Proc"},{"key":"hep31065-bib-0489-20241017","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.transproceed.2005.03.145","article-title":"Withdrawal of steroids: a randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitis","volume":"37","year":"2005","journal-title":"Transplant Proc"},{"key":"hep31065-bib-0490-20241017","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jhep.2005.12.010","article-title":"Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study","volume":"44","year":"2006","journal-title":"J Hepatol"},{"key":"hep31065-bib-0491-20241017","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0492-20241017","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1432-2277.2009.00893.x","article-title":"Corticosteroid\u2010free immunosuppression in liver transplantation: a meta\u2010analysis and meta\u2010regression of outcomes","volume":"22","year":"2009","journal-title":"Transpl Int"},{"key":"hep31065-bib-0493-20241017","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.3748\/wjg.v20.i31.10703","article-title":"Corticosteroid\u2010free immunosuppression in liver transplantation: an evidence\u2010based review","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"hep31065-bib-0494-20241017","article-title":"Glucocorticosteroid\u2010free versus glucocorticosteroid\u2010containing immunosuppression for liver transplanted patients","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"hep31065-bib-0495-20241017","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/TXD.0000000000000693","article-title":"Outcomes of liver transplant recipients with autoimmune liver disease using long\u2010term dual immunosuppression regimen without corticosteroid","volume":"3","year":"2017","journal-title":"Transplant Direct"},{"key":"hep31065-bib-0496-20241017","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.25206","article-title":"Pro: steroids can be withdrawn after transplant in recipients with autoimmune hepatitis","volume":"24","year":"2018","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0497-20241017","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation","volume":"66","year":"1998","journal-title":"Transplantation"},{"key":"hep31065-bib-0498-20241017","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/s10620-012-2179-3","article-title":"Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation","volume":"57","year":"2012","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0499-20241017","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation","volume":"45","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0500-20241017","article-title":"Histologic surveillance after liver transplantation due to autoimmune hepatitis","volume":"31","year":"2017","journal-title":"Clin Transplant"},{"key":"hep31065-bib-0501-20241017","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/lt.25375","article-title":"Recurrent and de novo autoimmune hepatitis","volume":"25","year":"2019","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0502-20241017","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1111\/ajt.13828","article-title":"First\u2010degree living\u2010related donor liver transplantation in autoimmune liver diseases","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"hep31065-bib-0503-20241017","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De\u2010novo autoimmune hepatitis after liver transplantation","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"hep31065-bib-0504-20241017","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-200103150-00016","article-title":"De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation","volume":"71","year":"2001","journal-title":"Transplantation"},{"key":"hep31065-bib-0505-20241017","first-page":"131","article-title":"Autoimmune hepatitis as a late complication of liver transplantation","volume":"32","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0506-20241017","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.TP.0000132328.33460.43","article-title":"Outcome and risk factors of de novo autoimmune hepatitis in living\u2010donor liver transplantation","volume":"78","year":"2004","journal-title":"Transplantation"},{"key":"hep31065-bib-0507-20241017","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1399-3046.2005.00470.x","article-title":"Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation","volume":"10","year":"2006","journal-title":"Pediatr Transplant"},{"key":"hep31065-bib-0508-20241017","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1600-6143.2006.01717.x","article-title":"Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis","volume":"7","year":"2007","journal-title":"Am J Transplant"},{"key":"hep31065-bib-0509-20241017","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.transproceed.2011.05.030","article-title":"De novo autoimmune hepatitis in Korean children after liver transplantation: a single institution's experience","volume":"43","year":"2011","journal-title":"Transplant Proc"},{"key":"hep31065-bib-0510-20241017","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.26756","article-title":"Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults","volume":"34","year":"2001","journal-title":"Hepatology"},{"key":"hep31065-bib-0511-20241017","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.510300103","article-title":"Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis","volume":"30","year":"1999","journal-title":"Hepatology"},{"key":"hep31065-bib-0512-20241017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/jlts.2001.23792","article-title":"Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post\u2013liver transplantation","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0513-20241017","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-2005-916328","article-title":"Auxiliary partial orthotopic liver transplantation with de novo autoimmune hepatitis in the allograft and leftover primary biliary cirrhosis in the native liver","volume":"25","year":"2005","journal-title":"Semin Liver Dis"},{"key":"hep31065-bib-0514-20241017","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.transproceed.2006.03.071","article-title":"De novo autoimmune hepatitis following liver transplantation for primary biliary cirrhosis","volume":"38","year":"2006","journal-title":"Transplant Proc"},{"key":"hep31065-bib-0515-20241017","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1399-0012.2007.00787.x","article-title":"De novo autoimmune hepatitis following living\u2010donor liver transplantation for primary biliary cirrhosis","volume":"22","year":"2008","journal-title":"Clin Transplant"},{"key":"hep31065-bib-0516-20241017","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/j.transproceed.2010.08.062","article-title":"De novo autoimmune hepatitis with centrilobular necrosis following liver transplantation for primary biliary cirrhosis: a case report","volume":"42","year":"2010","journal-title":"Transplant Proc"},{"key":"hep31065-bib-0517-20241017","first-page":"535","article-title":"Antibodies against glutathione S\u2010transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation","volume":"126","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"hep31065-bib-0518-20241017","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gut.2006.092064","article-title":"High incidence of allograft dysfunction in liver transplanted patients treated with pegylated\u2010interferon alpha\u20102b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?","volume":"56","year":"2007","journal-title":"Gut"},{"key":"hep31065-bib-0519-20241017","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0031-1272834","article-title":"De novo autoimmune hepatitis after liver transplantation","volume":"31","year":"2011","journal-title":"Semin Liver Dis"},{"key":"hep31065-bib-0520-20241017","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1478-3231.2012.02832.x","article-title":"Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation","volume":"32","year":"2012","journal-title":"Liver Int"},{"key":"hep31065-bib-0521-20241017","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2018.10.023","article-title":"De novo autoimmune hepatitis\u2014is this different in adults compared to children?","volume":"95","year":"2018","journal-title":"J Autoimmun"},{"key":"hep31065-bib-0522-20241017","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/lt.21447","article-title":"Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0523-20241017","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1111\/ajt.12413","article-title":"\u201cPlasma cell hepatitis\u201d in liver allografts: identification and characterization of an IgG4\u2010rich cohort","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"hep31065-bib-0524-20241017","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"2016 comprehensive update of the Banff Working Group on liver allograft pathology: introduction of antibody\u2010mediated rejection","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"hep31065-bib-0525-20241017","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/lt.21518","article-title":"Plasma cell hepatitis in liver allografts: variant of rejection or autoimmune hepatitis?","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0526-20241017","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MOT.0b013e3283536622","article-title":"Plasma cell hepatitis (de\u2010novo autoimmune hepatitis) developing post liver transplantation","volume":"17","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"hep31065-bib-0527-20241017","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1053\/j.gastro.2012.01.030","article-title":"Risk for immune\u2010mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon","volume":"142","year":"2012","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0528-20241017","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S2468-1253(18)30043-8","article-title":"Unmet needs and new models for future trials in autoimmune hepatitis","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"hep31065-bib-0529-20241017","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/apt.12825","article-title":"Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets","volume":"40","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0530-20241017","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/1744666X.2017.1319764","article-title":"Evolving paradigm for treatment of autoimmune hepatitis","volume":"13","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"hep31065-bib-0531-20241017","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/apt.14324","article-title":"Review article: next\u2010generation transformative advances in the pathogenesis and management of autoimmune hepatitis","volume":"46","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0532-20241017","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1007\/s10620-016-4247-6","article-title":"Nature and implications of oxidative and nitrosative stresses in autoimmune hepatitis","volume":"61","year":"2016","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0533-20241017","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1007\/s10620-016-4254-7","article-title":"Targeting hepatic fibrosis in autoimmune hepatitis","volume":"61","year":"2016","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0534-20241017","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/17474124.2015.1019470","article-title":"Adoptive cell transfer in autoimmune hepatitis","volume":"9","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"hep31065-bib-0535-20241017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.26023","article-title":"Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance","volume":"57","year":"2013","journal-title":"Hepatology"},{"key":"hep31065-bib-0536-20241017","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/17474124.2018.1453356","article-title":"Emerging therapeutic biomarkers of autoimmune hepatitis and their impact on current and future management","volume":"12","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"hep31065-bib-0537-20241017","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/jgh.12340","article-title":"Anti\u2010programmed cell death\u20101 antibody as a new serological marker for type 1 autoimmune hepatitis","volume":"29","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"hep31065-bib-0538-20241017","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/00365521.2016.1233576","article-title":"Soluble programmed death\u20101 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis","volume":"52","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"hep31065-bib-0539-20241017","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/hep.26664","article-title":"The role of macrophage migration inhibitory factor in autoimmune liver disease","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"hep31065-bib-0540-20241017","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1007\/s10620-016-4322-z","article-title":"A macrophage migration inhibitory factor polymorphism is associated with autoimmune hepatitis severity in US and Japanese patients","volume":"61","year":"2016","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0541-20241017","article-title":"Circulating microRNA profiles in patients with type\u20101 autoimmune hepatitis","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"hep31065-bib-0542-20241017","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/apt.13801","article-title":"Single\u2010centre experience of the macrophage activation marker soluble (s)CD163\u2014associations with disease activity and treatment response in patients with autoimmune hepatitis","volume":"44","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31065-bib-0543-20241017","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1021\/pr500462f","article-title":"Metabolomic profiling of autoimmune hepatitis: the diagnostic utility of nuclear magnetic resonance spectroscopy","volume":"13","year":"2014","journal-title":"J Proteome Res"},{"key":"hep31065-bib-0544-20241017","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1499-3872(15)60393-9","article-title":"A serum metabolomic analysis for diagnosis and biomarker discovery of primary biliary cirrhosis and autoimmune hepatitis","volume":"14","year":"2015","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"hep31065-bib-0545-20241017","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12026-019-9068-1","article-title":"Tryptophan\u2010kynurenine profile in pediatric autoimmune hepatitis","volume":"67","year":"2019","journal-title":"Immunol Res"},{"key":"hep31065-bib-0546-20241017","article-title":"Epigenetic changes and their implications in autoimmune hepatitis","volume":"48","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"hep31065-bib-0547-20241017","doi-asserted-by":"crossref","first-page":"9257","DOI":"10.3748\/wjg.v22.i42.9257","article-title":"Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis","volume":"22","year":"2016","journal-title":"World J Gastroenterol"},{"key":"hep31065-bib-0548-20241017","first-page":"5153","article-title":"Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis","volume":"8","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"hep31065-bib-0549-20241017","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/hep.27998","article-title":"A novel \u201chumanized mouse\u201d model for autoimmune hepatitis and the association of gut microbiota with liver inflammation","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"hep31065-bib-0550-20241017","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.1233521","article-title":"Sex differences in the gut microbiome drive hormone\u2010dependent regulation of autoimmunity","volume":"339","year":"2013","journal-title":"Science"},{"key":"hep31065-bib-0551-20241017","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.immuni.2013.08.013","article-title":"Gender bias in autoimmunity is influenced by microbiota","volume":"39","year":"2013","journal-title":"Immunity"},{"key":"hep31065-bib-0552-20241017","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4161\/gmic.29795","article-title":"Microbiome manipulation modifies sex\u2010specific risk for autoimmunity","volume":"5","year":"2014","journal-title":"Gut Microbes"},{"key":"hep31065-bib-0553-20241017","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/s10620-018-5072-x","article-title":"Under\u2010evaluated or unassessed pathogenic pathways in autoimmune hepatitis and implications for future management","volume":"63","year":"2018","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0554-20241017","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/0016-5085(92)91518-9","article-title":"Frequency and significance of antibodies to liver\/kidney microsome type 1 in adults with chronic active hepatitis","volume":"103","year":"1992","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0555-20241017","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0029-1233529","article-title":"Autoimmune hepatitis in children: what is different from adult AIH?","volume":"29","year":"2009","journal-title":"Semin Liver Dis"},{"key":"hep31065-bib-0556-20241017","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MPG.0000000000001363","article-title":"Prevalence and significance of autoantibodies in children with acute liver failure","volume":"64","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0557-20241017","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","article-title":"Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis","volume":"107","year":"1994","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0558-20241017","first-page":"621","article-title":"Smooth muscle autoantibodies and autoantigens","volume":"38","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"hep31065-bib-0559-20241017","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM\u20101 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P\u2010450 monooxygenase","volume":"88","year":"1991","journal-title":"J Clin Invest"},{"key":"hep31065-bib-0560-20241017","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","article-title":"Autoantibodies against a serine tRNA\u2010protein complex implicated in cotranslational selenocysteine insertion","volume":"89","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"hep31065-bib-0561-20241017","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"hep31065-bib-0562-20241017","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/jhep.2001.22218","article-title":"Soluble liver antigen: isolation of a 35\u2010kd recombinant protein (SLA\u2010p35) specifically recognizing sera from patients with autoimmune hepatitis","volume":"33","year":"2001","journal-title":"Hepatology"},{"key":"hep31065-bib-0563-20241017","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2009.07.005","article-title":"SLA\/LP\/tRNP((Ser)Sec) antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract","volume":"34","year":"2010","journal-title":"J Autoimmun"},{"key":"hep31065-bib-0564-20241017","first-page":"364","article-title":"Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients with type\u20101 autoimmune hepatitis","volume":"121","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"hep31065-bib-0565-20241017","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.510280207","article-title":"Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins","volume":"28","year":"1998","journal-title":"Hepatology"},{"key":"hep31065-bib-0566-20241017","first-page":"439","article-title":"Diagnostic accuracy of atypical p\u2010ANCA in autoimmune hepatitis using ROC\u2010 and multivariate regression analysis","volume":"9","year":"2004","journal-title":"Eur J Med Res"},{"key":"hep31065-bib-0567-20241017","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2249.2003.02195.x","article-title":"IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis","volume":"133","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"hep31065-bib-0568-20241017","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.autrev.2010.12.009","article-title":"Alpha\u2010actinin: a multidisciplinary protein with important role in B\u2010cell driven autoimmunity","volume":"10","year":"2011","journal-title":"Autoimmun Rev"},{"key":"hep31065-bib-0569-20241017","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ\u2010specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","year":"1999","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0570-20241017","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/jhep.2001.27179","article-title":"Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1","volume":"34","year":"2001","journal-title":"Hepatology"},{"key":"hep31065-bib-0571-20241017","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","article-title":"Liver cytosolic 1 antigen\u2010antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"36","year":"1995","journal-title":"Gut"},{"key":"hep31065-bib-0572-20241017","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0003-9861(90)90541-6","article-title":"Identification of cytochrome P450IA2 as a human autoantigen","volume":"280","year":"1990","journal-title":"Arch Biochem Biophys"},{"key":"hep31065-bib-0573-20241017","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00008571-199706000-00002","article-title":"Epitope mapping of human CYP1A2 in dihydralazine\u2010induced autoimmune hepatitis","volume":"7","year":"1997","journal-title":"Pharmacogenetics"},{"key":"hep31065-bib-0574-20241017","first-page":"280","article-title":"Anti\u2010liver microsomes autoantibodies and dihydralazine\u2010induced hepatitis: specificity of autoantibodies and inductive capacity of the drug","volume":"42","year":"1992","journal-title":"Mol Pharmacol"},{"key":"hep31065-bib-0575-20241017","first-page":"1353","article-title":"Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1","volume":"82","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"hep31065-bib-0576-20241017","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM198905253202104","article-title":"Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis","volume":"320","year":"1989","journal-title":"N Engl J Med"},{"key":"hep31065-bib-0577-20241017","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/BF01296447","article-title":"Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis","volume":"31","year":"1986","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0578-20241017","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MCG.0b013e3181587d18","article-title":"Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis","volume":"42","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"hep31065-bib-0579-20241017","first-page":"547","article-title":"Propylthiouracil hepatotoxicity mimicking autoimmune chronic active hepatitis in a girl","volume":"8","year":"1989","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0580-20241017","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archinte.1975.00330020123017","article-title":"Liver disease caused by propylthiouracil","volume":"135","year":"1975","journal-title":"Arch Intern Med"},{"key":"hep31065-bib-0581-20241017","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/17425255.2019.1574744","article-title":"Hepatotoxicity induced by immune checkpoint inhibitors: a comprehensive review including current and alternative management strategies","volume":"15","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"hep31065-bib-0582-20241017","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0016-5085(19)32568-5","article-title":"Isoniazid\u2010associated hepatitis in 114 patients","volume":"69","year":"1975","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0583-20241017","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/hep.20205","article-title":"Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity","volume":"39","year":"2004","journal-title":"Hepatology"},{"key":"hep31065-bib-0584-20241017","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/BF01316809","article-title":"Diclofenac induced hepatitis. 3 cases with features of autoimmune chronic active hepatitis","volume":"38","year":"1993","journal-title":"Dig Dis Sci"},{"key":"hep31065-bib-0585-20241017","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0016-5085(75)80018-7","article-title":"Severe hepatitis from methyldopa","volume":"68","year":"1975","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0586-20241017","first-page":"941","article-title":"Methyldopa hepatitis. A report of six cases and review of the literature","volume":"60","year":"1976","journal-title":"Am J Med"},{"key":"hep31065-bib-0587-20241017","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archinte.1983.00350030206040","article-title":"Methyldopa\u2010induced immune hemolytic anemia and chronic active hepatitis","volume":"143","year":"1983","journal-title":"Arch Intern Med"},{"key":"hep31065-bib-0588-20241017","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1080\/21645515.2016.1199310","article-title":"Pembrolizumab (Keytruda)","volume":"12","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"hep31065-bib-0589-20241017","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/MCG.0b013e3181a745e7","article-title":"Adalimumab\u2010induced autoimmune hepatitis","volume":"44","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"hep31065-bib-0590-20241017","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/hep.23834","article-title":"Drug\u2010induced autoimmune hepatitis caused by anti\u2010tumor necrosis factor alpha agents","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"hep31065-bib-0591-20241017","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00228-011-1191-4","article-title":"Autoimmune hepatitis induced by adalimumab with successful switch to abatacept","volume":"68","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"hep31065-bib-0592-20241017","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1191\/0961203303lu313cr","article-title":"Drug\u2010induced lupus\u2010like syndrome associated with severe autoimmune hepatitis","volume":"12","year":"2003","journal-title":"Lupus"},{"key":"hep31065-bib-0593-20241017","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00042737-200308000-00014","article-title":"Autoimmune hepatitis revealed by atorvastatin","volume":"15","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep31065-bib-0594-20241017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2006.01838.x","article-title":"Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review","volume":"21","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"hep31065-bib-0595-20241017","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-0029-1240010","article-title":"Drug\u2010induced liver injury associated with statins","volume":"29","year":"2009","journal-title":"Semin Liver Dis"},{"key":"hep31065-bib-0596-20241017","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/cs0720263","article-title":"Halothane hepatitis: a model of immune mediated drug hepatotoxicity","volume":"72","year":"1987","journal-title":"Clin Sci (Lond)"},{"key":"hep31065-bib-0597-20241017","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-2797(98)00081-7","article-title":"Interindividual variability in P450\u2010dependent generation of neoantigens in halothane hepatitis","volume":"116","year":"1998","journal-title":"Chem Biol Interact"},{"key":"hep31065-bib-0598-20241017","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00042737-200505000-00019","article-title":"Rosuvastatin\u2010associated hepatitis with autoimmune features","volume":"17","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep31065-bib-0599-20241017","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.gme.0000142914.55849.6a","article-title":"Autoimmune hepatitis associated with the use of black cohosh: a case study","volume":"11","year":"2004","journal-title":"Menopause"},{"key":"hep31065-bib-0600-20241017","article-title":"Liver injury with features mimicking autoimmune hepatitis following the use of black cohosh","volume":"2009","year":"2009","journal-title":"Case Report Med"},{"key":"hep31065-bib-0601-20241017","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJM197110072851501","article-title":"Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin","volume":"285","year":"1971","journal-title":"N Engl J Med"},{"key":"hep31065-bib-0602-20241017","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000198597","article-title":"Chronic active hepatitis and giant multinucleated hepatocytes in adults treated with clometacin","volume":"22","year":"1981","journal-title":"Digestion"},{"key":"hep31065-bib-0603-20241017","first-page":"769","article-title":"Hepatitis caused by clometacin (Duperan). Retrospective study of 30 cases. A model of autoimmune drug\u2010induced hepatitis?","volume":"13","year":"1989","journal-title":"Gastroenterol Clin Biol"},{"key":"hep31065-bib-0604-20241017","first-page":"703","article-title":"Autoimmune hepatitis triggered by administration of an herbal medicine","volume":"92","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0605-20241017","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1172\/JCI114660","article-title":"Anti\u2010liver endoplasmic reticulum autoantibodies are directed against human cytochrome P\u2010450IA2. A specific marker of dihydralazine\u2010induced hepatitis","volume":"85","year":"1990","journal-title":"J Clin Invest"},{"key":"hep31065-bib-0606-20241017","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7326\/0003-4819-117-2-129","article-title":"Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity","volume":"117","year":"1992","journal-title":"Ann Intern Med"},{"key":"hep31065-bib-0607-20241017","first-page":"561","article-title":"A new anti\u2010liver\u2010kidney microsome antibody (anti\u2010LKM2) in tienilic acid\u2010induced hepatitis","volume":"55","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"hep31065-bib-0608-20241017","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/ajg.2010.5","article-title":"Hepatotoxicity due to hydroxycut: a case series","volume":"105","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"hep31065-bib-0609-20241017","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1021\/tx800409r","article-title":"Delineating liver events in trichloroethylene\u2010induced autoimmune hepatitis","volume":"22","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"hep31065-bib-0610-20241017","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0016-5085(86)90887-5","article-title":"Papaverine\u2010induced chronic liver disease","volume":"90","year":"1986","journal-title":"Gastroenterology"},{"key":"hep31065-bib-0611-20241017","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ncpgasthep1055","article-title":"A case of indometacin\u2010induced acute hepatitis developing into chronic autoimmune hepatitis","volume":"5","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"hep31065-bib-0612-20241017","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/COC.0b013e31802b4ef7","article-title":"An acute hepatitis resembling autoimmune hepatitis occurring during imatinib therapy in a gastrointestinal stromal tumor patient","volume":"32","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"hep31065-bib-0613-20241017","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0049-0172(99)80004-3","article-title":"Minocycline\u2010induced autoimmune syndromes: an overview","volume":"28","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"hep31065-bib-0614-20241017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","article-title":"Long\u2010term follow\u2010up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease","volume":"30","year":"1999","journal-title":"J Hepatol"},{"key":"hep31065-bib-0615-20241017","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis","volume":"32","year":"2000","journal-title":"Hepatology"},{"key":"hep31065-bib-0616-20241017","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence","volume":"52","year":"2003","journal-title":"Gut"},{"key":"hep31065-bib-0617-20241017","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0618-20241017","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00007890-200107270-00018","article-title":"Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine","volume":"72","year":"2001","journal-title":"Transplantation"},{"key":"hep31065-bib-0619-20241017","first-page":"331","article-title":"Recurrence of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation","volume":"68","year":"2005","journal-title":"Acta Gastroenterol Belg"},{"key":"hep31065-bib-0620-20241017","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0676.1997.tb01038.x","article-title":"Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"17","year":"1997","journal-title":"Liver"},{"key":"hep31065-bib-0621-20241017","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long\u2010term pathologic study","volume":"32","year":"2000","journal-title":"Hepatology"},{"key":"hep31065-bib-0622-20241017","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/jlts.2001.23085","article-title":"Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and outcome","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0623-20241017","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.21280","article-title":"Liver biopsy interpretation for causes of late liver allograft dysfunction","volume":"44","year":"2006","journal-title":"Hepatology"},{"key":"hep31065-bib-0624-20241017","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cgh.2011.10.028","article-title":"Autoimmune hepatitis after liver transplantation","volume":"10","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31065-bib-0625-20241017","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/jlts.2001.24638","article-title":"Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"key":"hep31065-bib-0626-20241017","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation","volume":"35","year":"2002","journal-title":"Hepatology"},{"key":"hep31065-bib-0627-20241017","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/01.TP.0000071522.74885.48","article-title":"Mycophenolatemofetil for immunosuppression after liver transplantation: a follow\u2010up study of 191 patients","volume":"76","year":"2003","journal-title":"Transplantation"},{"key":"hep31065-bib-0628-20241017","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","article-title":"Rapamycin successfully treats post\u2010transplant autoimmune hepatitis","volume":"5","year":"2005","journal-title":"Am J Transplant"},{"key":"hep31065-bib-0629-20241017","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.transproceed.2009.01.054","article-title":"Sirolimus in pediatric liver transplantation: a single\u2010center experience","volume":"41","year":"2009","journal-title":"Transplant Proc"},{"key":"hep31065-bib-0630-20241017","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"68","year":"1999","journal-title":"Transplantation"},{"key":"hep31065-bib-0631-20241017","first-page":"20","article-title":"Recurrence of autoimmune hepatitis in children after liver transplantation","volume":"25","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31065-bib-0632-20241017","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/TP.0b013e31821841ba","article-title":"The pattern of late mortality in liver transplant recipients in the United Kingdom","volume":"91","year":"2011","journal-title":"Transplantation"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.31065","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.31065","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.31065","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.31065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T20:07:09Z","timestamp":1729195629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.31065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":628,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.31065","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"2019-11-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}